<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS201309</article-id><article-id pub-id-type="doi">10.1101/2024.11.25.625291</article-id><article-id pub-id-type="archive">PPR945906</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Dynamic whole-body models for infant metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zaunseder</surname><given-names>Elaine</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Mohammad</surname><given-names>Faiz Khan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Mütze</surname><given-names>Ulrike</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kölker</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Heuveline</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Thiele</surname><given-names>Ines</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A6">6</xref><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref><xref ref-type="fn" rid="FN1">9</xref><xref ref-type="corresp" rid="CR1">10</xref></contrib></contrib-group><aff id="A1"><label>1</label>Digital Metabolic Twin Centre, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03bea9k73</institution-id><institution>University of Galway</institution></institution-wrap>, <country country="IE">Ireland</country></aff><aff id="A2"><label>2</label>School of Medicine, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03bea9k73</institution-id><institution>University of Galway</institution></institution-wrap>, <city>Galway</city>, <country country="IE">Ireland</country></aff><aff id="A3"><label>3</label>Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), <institution-wrap><institution-id institution-id-type="ror">https://ror.org/038t36y30</institution-id><institution>Heidelberg University</institution></institution-wrap>, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A4"><label>4</label>Data Mining and Uncertainty Quantification (DMQ), <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01f7bcy98</institution-id><institution>Heidelberg Institute for Theoretical Studies (HITS)</institution></institution-wrap>, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/038t36y30</institution-id><institution>Heidelberg University</institution></institution-wrap>, Medical Faculty of Heidelberg, Center for Pediatrics and Adolescent Medicine, Department of Pediatrics I, Division of Pediatric Neurology and Metabolic Medicine, <city>Heidelberg</city>, <country country="DE">Germany</country></aff><aff id="A6"><label>6</label>Discipline of Microbiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03bea9k73</institution-id><institution>University of Galway</institution></institution-wrap>, <city>Galway</city>, <country country="IR">Ireland</country></aff><aff id="A7"><label>7</label>Ryan Institute, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03bea9k73</institution-id><institution>University of Galway</institution></institution-wrap>, <city>Galway</city>, <country country="IR">Ireland</country></aff><aff id="A8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03f2ct267</institution-id><institution>APC Microbiome Ireland</institution></institution-wrap>, <city>Cork</city>, <country country="IR">Ireland</country></aff><author-notes><fn id="FN1"><label>9</label><p id="P1">Lead contact</p></fn><corresp id="CR1"><label>10</label>Correspondence: <email>ines.thiele@universityofgalway.ie</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>28</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>26</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><label>1</label><p id="P2">Comprehensive, sex-specific whole-body models (WBMs) accounting for organ-specific metabolism have been developed to allow for the simulation of adult and infant metabolism. These WBMs are evaluated daily, giving insights into metabolic flux changes that occur in one day of an infant’s or adult’s life. However, for medical applications, such as in metabolic diseases and their treatment, an evaluation and concentration predictions on a shorter time scale would be beneficial. Therefore, we developed a dynamic infant-WBM that couples metabolite dynamics in short time frames through physiology-based pharmacokinetic models with the existing infant whole-body models. We then tailored the dynamic infant-WBM enabling the prediction of isovalerylcarnitine (C5), a clinical biomarker used for the inherited metabolic disease isovaleric aciduria (IVA). Our results show that, as expected, the predicted C5 concentrations exceeded the newborn screening thresholds during the time (36 - 72 hours) newborn screening blood samples are taken in the IVA models but not in models simulating healthy infants. We also demonstrate how the dynamic infant-WBMs can be used to test the effect changes in dietary intake have on the biomarker. Since the dynamic infant-WBMs were parametrised with literature-derived experimental or estimated values, we show how uncertainty quantification can be applied to quantify the parameter uncertainties. We found that the fractional unbound plasma needed to be estimated correctly, as this parameter strongly impacted C5 concentration predictions of the dynamic infant-WBMs. Overall, the dynamic infant-WBMs hold promise for personalised medicine, as it enables personalised biomarker concentration predictions of healthy and diseased infant metabolism in various time intervals.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><label>2</label><title>Introduction</title><p id="P3">Newborn screening programs aim at the early detection of treatable rare diseases that pose a risk to the physical and mental development of affected children. Ideally, this identification should occur pre-symptomatically to significantly reduce morbidity and mortality, making these programs highly successful instruments of secondary prevention [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R3">3</xref>] Therefore, blood samples from newborns are collected on the first days of life (i.e., in Germany at 36 - 72 h of life) and sent to a newborn screening centre for analysis [<xref ref-type="bibr" rid="R4">4</xref>]. As soon as infants with an inherited metabolic disease (IMD) are identified, beneficial treatment can start. However, due to the substantial variability of IMDs, the disease management and therapy need to be adapted to the age-dependent requirements and the individual disease severity requiring carefully personalised treatments for each patient [<xref ref-type="bibr" rid="R5">5</xref>].</p><p id="P4">Numerous successive generic reconstructions of human metabolism have been published, such as the Recon series [<xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>] and the human metabolic reaction series [<xref ref-type="bibr" rid="R10">10</xref>], which presented the first generic reconstructions of the human metabolic network using cell-based models. Subsequently, sex-specific whole-body models of human metabolism (WBMs) have been constructed by integrating information from Recon3D, organ-specific details, and omics data [<xref ref-type="bibr" rid="R11">11</xref>]. These models capture the metabolism of 26 organs and six blood cell types in two, male and female, adult models named <italic>Harvey</italic> and <italic>Harvetta</italic> [<xref ref-type="bibr" rid="R11">11</xref>]. The goal of these WBMs is to model the metabolism of the entire human, and not solely on a cellular level, as seen in the Recon models [<xref ref-type="bibr" rid="R11">11</xref>]. All of these models focus on adult metabolism. To enable the investigation of infantile metabolism, the sex-specific infant whole-body models (infant-WBMs) have been developed [<xref ref-type="bibr" rid="R12">12</xref>] spanning the first 180 days of life. For the creation of these models detailed knowledge of infants’ physiology, metabolic processes, and newborn screening data was used. They account for organ-specific parameters and included in detail the energy demand for brain development, heart function, muscular activity, and thermoregulation. The models represent active infant metabolism and predict infant growth between zero and six months in agreement with growth trajectories by the WHO [<xref ref-type="bibr" rid="R13">13</xref>].</p><p id="P5">These generic, cell level, or whole-body genome-scale metabolic models can be used to predict reaction fluxes using constraint-based modelling [<xref ref-type="bibr" rid="R14">14</xref>], with flux balance analysis (FBA) being a preferred analysis method [<xref ref-type="bibr" rid="R15">15</xref>]. Therefore, steady-state is assumed [<xref ref-type="bibr" rid="R16">16</xref>], i.e., the concentration of metabolites in cells or organs remains constant over time, corresponding to an overall balance between metabolite inflow and outflow [<xref ref-type="bibr" rid="R15">15</xref>], and the simulation correspond to a specific time interval (e.g., daily). Consequently, this approach cannot be used to investigate short-term effects, such as responses to perturbations or dynamic variations in gene expression and metabolite levels. Such analysis would require the evaluation on shorter time scales with dynamic metabolite concentrations.</p><p id="P6">One possibility to capture the dynamic features and changes of human metabolism is through kinetic modelling, such as in physiological-based pharmacokinetic (PBPK) modelling [<xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R18">18</xref>]. These PBPK models can be used to predict allosteric and post-translational regulation, alterations in metabolite concentrations, and considerations of thermodynamics [<xref ref-type="bibr" rid="R19">19</xref>]. PBPK models require extensive parametrisation, which often need to be estimated through extensive clinical studies. They describe absorption, distribution, metabolism, and excretion (ADME) of a particular drug or metabolite, while omitting other metabolic processes occurring in the human body. Consequently, combining dynamic and constraint-based models is of great interest as it would represent the dynamic nature of a particular pathway while accounting for the complexity of the overall metabolic network.</p><p id="P7">Combined dynamic and constraint-based models have been developed since they increase the spatial and temporal resolution of genome-scale metabolic models [<xref ref-type="bibr" rid="R19">19</xref>]. For instance, the unsteady-state FBA approach has been developed to improve the accurate prediction of metabolic flux states for red blood cells by relaxing the steady-state assumption [<xref ref-type="bibr" rid="R20">20</xref>]. Mannan et al [<xref ref-type="bibr" rid="R21">21</xref>] introduced an approach, which integrates parameters from a genome-scale metabolic network model into a kinetic model of the central carbon metabolism of <italic>E. coli.</italic> Another modelling framework considered both reaction kinetics and network connectivity constraints, emphasizing the role of metabolic network connectivity in influencing cellular control over metabolite levels [<xref ref-type="bibr" rid="R22">22</xref>]. For human metabolism, Mohammad et al [<xref ref-type="bibr" rid="R18">18</xref>] integrated PBPK modelling and constraint-based metabolic models to investigate the gut-brain axis for patients with an autism spectrum disorder. Moreover, Guebila et al [<xref ref-type="bibr" rid="R23">23</xref>] integrated a comprehensive PBPK model of glucose regulation by insulin, glucagon, and incretins with WBMs to perform dynamic flux balance analysis for type 1 diabetes. Furthermore, to analyse the effect of processes and genetic variations in ethanol metabolism, Zhu et al [<xref ref-type="bibr" rid="R24">24</xref>] integrated a PBPK model with the human whole-body models <italic>Harvey</italic> and <italic>Harvetta</italic> [<xref ref-type="bibr" rid="R11">11</xref>]. However, no dynamic whole-body model has been developed to analyse infant metabolism.</p><p id="P8">In medical applications, metabolic modelling is increasingly utilised, encompassing tasks, such as identifying drug targets [<xref ref-type="bibr" rid="R25">25</xref>] and off-target drug effects [<xref ref-type="bibr" rid="R9">9</xref>], studying cancer metabolism [<xref ref-type="bibr" rid="R26">26</xref>], enhancing the understanding of microbial interactions with the host organism [<xref ref-type="bibr" rid="R27">27</xref>], and also emerging as a field for investigating IMDs related to newborn screening [<xref ref-type="bibr" rid="R28">28</xref>]. IMD analysis is utilised in metabolic modelling to demonstrate the human metabolic model’s capability to accurately predict known biomarkers. Furthermore, a dietary treatment analysis with the infant-WBMs showed that these models can correctly simulate the effect of dietary interventions on patients with an IMD [<xref ref-type="bibr" rid="R12">12</xref>]. IMDs often involve a disruption of the normal metabolite flux [<xref ref-type="bibr" rid="R5">5</xref>]. Therefore, analysing the metabolic flux over time is significantly more informative for IMDs than the static measurement of intermediary metabolites [<xref ref-type="bibr" rid="R5">5</xref>]. For dynamic evaluations of IMD biomarker prediction in metabolic models, an approach combining PBPK modelling with cell-based metabolic human models has been developed [<xref ref-type="bibr" rid="R29">29</xref>].</p><p id="P9">Metabolic reconstructions try to mimic the dynamics in human metabolism as closely as possible but are limited by multiple heterogeneous sources of uncertainty [<xref ref-type="bibr" rid="R30">30</xref>]. Uncertainties in the metabolic reconstruction, such as the genome annotation, environment specification, biomass formulation, and network gap-filling, as well as the choice of flux simulation method can arise due to different choices and data used at these points [<xref ref-type="bibr" rid="R30">30</xref>]. To quantify these uncertainties, different approaches, including probabilistic metabolic reaction annotation [<xref ref-type="bibr" rid="R31">31</xref>], Monte-Carlo sampling [<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R33">33</xref>], and ensemble sampling [<xref ref-type="bibr" rid="R34">34</xref>], have been applied. Quantifying the uncertainty can test the reliability of the models along with the uncertainty associated with parameters and possible measurement errors coupled with their impact on the model’s output.</p><p id="P10">In this study, we developed a dynamic infant-WBM by coupling the metabolite dynamics from an infant-specific PBPK model, which simulates the change of biomarker concentration over time in different organs, the blood compartment, and the infant-WBM. This coupled model was then used to predict a known biomarker of an IMD over a specified time interval relevant for newborn screening. Moreover, we used the developed model to simulate the effect a reduction of a dietary amino acid intake has on the biomarker concentration. Further, we show how uncertainty quantification is used to analyse the reliability of the dynamic infant-WBMs and understand the impact of parameter uncertainties on the metabolite concentration prediction.</p></sec><sec id="S2" sec-type="results"><label>3</label><title>Results</title><sec id="S3"><label>3.1</label><title>Procedure to simulate dynamics with an infant-WBM-PBPK model</title><p id="P11">The development of dynamic infant-WBMs was based on the coupling of infant PBPK models [<xref ref-type="bibr" rid="R35">35</xref>] and sex-specific infant-WBMs [<xref ref-type="bibr" rid="R12">12</xref>] such that metabolite concentration predictions could be used to update the constraints on the fluxes within the infant-WBM model and vice versa (<xref ref-type="fig" rid="F1">Figure 1</xref>). Therefore, we devised a four-step procedure to couple PBPK models and infant whole-body models such that dynamic evaluations of biomarkers and drugs are possible for individual infants (see Method section for details). This process first included the adaptation of an existing PBPK model [<xref ref-type="bibr" rid="R18">18</xref>] to represent infant physiology, including the appropriate parametrisation of organ and blood volumes, organ densities, the body surface area, height and blood flow rates [<xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>]. The second step adapts compound-specific parameters, where the compound can either be a drug or a metabolite, e.g., a biomarker for an IMD. Therefore, parameter information, such as lipophilicity, molecular weight, and fractional unbound plasma rate, were used to calculate the compound-specific tissue partition coefficient [<xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R40">40</xref>]. Further, it included information on urinary or faecal excretion of a compound [<xref ref-type="bibr" rid="R41">41</xref>]. The third step prepares for solving the system of ordinary differential equations (ODEs) of the PBPK model, which included defining parameters, such as frequency and time interval of the simulation. In the fourth step, the PBPK and WBM models were then iteratively coupled by i) setting the initial values for the compound concentration in each organ in the PBPK model, ii) computing the metabolite concentration with the PBPK model, iii) updating the corresponding bounds of the metabolite in each organ in the infant-WBMs with the predictions from the PBPK model, iv) optimising the updated infant-WBM for the desired objective function (e.g., metabolite accumulation in the blood), and v) using the predicted flux from the infant-WBM to update the PBPK model. From this point, step four is repeated until the end of the defined time interval is reached. For details on the developed process and the individual steps see the Method section and our code published at <ext-link ext-link-type="uri" xlink:href="https://github.com/ThieleLab">https://github.com/ThieleLab</ext-link>.</p></sec><sec id="S4"><label>3.2</label><title>Application of the procedure to dynamic infant-WBM for biomarker prediction</title><p id="P12">In the following, we demonstrate this four-step procedure by developing a dynamic infant-WBM for isovalerylcarnitine (C5), which is increased in the blood in patients with isovaleric aciduria (IVA, OMIM: #243500) [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R42">42</xref>, <xref ref-type="bibr" rid="R43">43</xref>]. Isovaleric aciduria (IVA) is caused by a deficiency in the activity of the mitochondrial FAD-dependent enzyme isovaleryl-CoA dehydrogenase due to biallelic pathogenic variants in the <italic>IVD</italic> gene (Entrez gene ID: 3712). The whole-body model includes all reactions necessary for the correct biochemical representation of IVA. In brief, isovaleryl-CoA (VMH ID: ivcoa) is generated in the mitochondrial compartment through the isovaleryl-CoA dehydrogenase reaction (VMH ID: ACOAD8m). Isovaleryl-CoA can then undergo further metabolism or be transported into the cytosol (VMH ID: IV-COAACBP), where it undergoes transesterification with carnitine, resulting in C5 (VMH ID: ivcrn) via the reaction (VMH ID: C50CPT1). C5 is then transported outside the cell (organ in our case, VMH ID: IVCRNe). Additionally, a further elimination route of isovaleryl-CoA exists via transesterification with glycine in the glycine N-acyltransferase reaction (VMH ID: RE2427M), yielding isovaleryl-glycine (VMH ID: CE4968). The virtual metabolic human identifiers (VMH IDs) referred to in this study represent the reaction names of the corresponding organ-specific reactions in the infant-WBM models. The non-organ-specific part of the VMH ID can be searched in the VMH database (<ext-link ext-link-type="uri" xlink:href="https://www.vmh.life">https://www.vmh.life</ext-link>) for further information.</p><sec id="S5"><title>Step 1: Adaptation of an existing PBPK model for C5 prediction</title><p id="P13">First, a published PBPK model [<xref ref-type="bibr" rid="R44">44</xref>] was obtained which describes the dynamics of a system with 23 ODEs. These ODEs describe the time-dependent compound concentration in 14 tissues (such as adipose tissue, brain, small intestine, large intestine, heart, kidney, liver, lung, muscle, pancreas, skin, spleen, stomach, and bone), two blood compartments (artery and venous blood), two excretion compartments (renal and bile), as well as the transit from bile to small and large intestine lumen (see Method section for further details). We extended the PBPK model for the metabolic activity of the isovaleryl-CoA dehydrogenase reaction by assuming Michaelis-Menten kinetics. Therefore, we retrieved experimental data from the literature (<italic>K<sub>m</sub></italic> = 125 μmol [<xref ref-type="bibr" rid="R45">45</xref>], <xref ref-type="supplementary-material" rid="SD2">Table S2 (D)</xref>). The maximum velocity of the compound-producing reaction was fixed to <italic>V<sub>max</sub></italic> = 0.225 mol/min.</p><p id="P14">To allow for the iterative coupling between the PBPK and the infant-WBM (in Step 4), the overlapping organ and reactions in the PBPK and the infant-WBM models were identified. In the infant-WBM, exchange reactions (VMH ID: EX_ivcrn(e)_[bc] between organs and the blood compartment existed for C5 (VMH ID: ivcrn) in the lung (Lung_EX_ivcrn(e)_[bc]), heart (Heart_EX_ivcrn(e)_[bc]), muscle (Muscle_EX_ivcrn(e)_[bc]), and kidney (Kidney_EX_ivcrn(e)_[bc]). The PBPK model was reduced to these organs, the blood compartment, and the respective excretion pathways, resulting in the following reduced PBPK model for dynamic C5 prediction. The isovaleryl-CoA dehydrogenase reaction (VMH ID: ACOAD8m) was present in these four organs, as well as 15 other organs in the infant-WBMs. Hence, the flux through this reaction was coupled for the overlapping organs between the reduced PBPK model and the infant-WBMs. At the end, the PBPK part of the coupled model consisted of the following mass-balance equations: <disp-formula id="FD1"><mml:math id="M1"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>H</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>K</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>L</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>M</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>A</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>y</mml:mi></mml:mstyle><mml:mtext> </mml:mtext><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>V</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi></mml:mstyle><mml:mtext> </mml:mtext><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mi>O</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mn>8</mml:mn><mml:mi>m</mml:mi></mml:mstyle><mml:mo>:</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>, where <italic>C<sub>T</sub></italic> represents the concentration of C5 in a specific tissue T, <italic>V<sub>T</sub></italic> is the tissue volume, <italic>Q<sub>T</sub></italic> the blood flow rate, and <italic>K<sub>T</sub></italic> the calculated organ-specific tissue partition coefficient for C5. Furthermore, <italic>cl<sub>urine</sub></italic> represent renal clearance for C5. <italic>v̂<sub>organ</sub></italic> is the predicted flux value for each C5 organ-specific exchange reaction in the infant-WBM for each organ (see Method section for more details).</p><p id="P15">Next, we adapted this PBPK model for C5 by adjusting individual-specific, physiological parameters. To acquire these parameters for infants, we obtained the female and male infant-WBMs at age day one from the infant-WBM resource [<xref ref-type="bibr" rid="R12">12</xref>]. The PBPK model was assigned a body weight of 3.3 kg for male infants and 3.2 for female infants. Based on the body weight and measured references from newborns [<xref ref-type="bibr" rid="R46">46</xref>], the organ weights and organ-specific blood flow rates were determined as follows. The organ flow rates were obtained from the organ flow rate parameters used for the infant-WBM (SI material in [<xref ref-type="bibr" rid="R12">12</xref>]), which were reported in l/min/kg tissue and, hence, needed to be converted into l/h/organ [<xref ref-type="bibr" rid="R12">12</xref>] (<xref ref-type="supplementary-material" rid="SD2">Table S2 (A), (B)</xref>). The blood flow rate for venous and arterial blood was estimated as 3 l/h, since the blood flow rate ranges from 10 to 50 ml/min in infants weighing less than 5 kg [<xref ref-type="bibr" rid="R38">38</xref>], leading to an estimation of 0.6 - 3 l/h by the multiplication with 60/1000. The calculation of the organ volumes was based on the organ weights reported in the infant-WBMs and the respective organ density was obtained from literature [<xref ref-type="bibr" rid="R36">36</xref>] (<xref ref-type="supplementary-material" rid="SD2">Table S2 (C)</xref>). The venous and arterial blood volume estimations were based on the total blood volume resulting in 144 ml of blood in both compartments for a 3.3 kg newborn at day 1 (total blood volume: 288 ml). This value was comparable to the blood range of newborns at 72 hours of age (75 to 107 ml/kg) ranging between 248 - 353 ml for a 3.3 kg infant [<xref ref-type="bibr" rid="R47">47</xref>]. The body surface area was estimated as 0.2141<italic>m</italic><sup>2</sup> using the Mosteller method [<xref ref-type="bibr" rid="R48">48</xref>], with the average height of 50 cm for male newborns [<xref ref-type="bibr" rid="R37">37</xref>]. Similar to Toroghi et al [<xref ref-type="bibr" rid="R29">29</xref>], the physiological and physicochemical properties in the PBPK model were assumed to be constant over time.</p></sec><sec id="S6"><title>Step 2: Determination of compound-specific parameters for C5 prediction</title><p id="P16">Next, we identified the C5-specific parameters from the literature and databases, such as the Human Metabolome DataBase (HMDB) [<xref ref-type="bibr" rid="R40">40</xref>] (<xref ref-type="supplementary-material" rid="SD2">Table S2 (D)</xref>. The molecular weight of C5 is 245.3153 g/mol [<xref ref-type="bibr" rid="R40">40</xref>]. Further, a predicted lipophilicity value <italic>l</italic> = −2 was obtained from the HMDB [<xref ref-type="bibr" rid="R40">40</xref>]. The fractional unbound plasma was determined in experimental studies as <inline-formula><mml:math id="M2"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.933</mml:mn></mml:mrow></mml:math></inline-formula> for all tissues <italic>T</italic> [<xref ref-type="bibr" rid="R49">49</xref>]. Similar to the study from Toroghi et al [<xref ref-type="bibr" rid="R29">29</xref>], the blood-to-plasma ratio was set to <italic>B</italic> = 1.</p><p id="P17">Based on these parameters and predefined specific volume fractions of neutral lipid, phospholipid, and water in tissue and plasma [<xref ref-type="bibr" rid="R50">50</xref>], the tissue partition coefficient <italic>K<sub>T</sub></italic> was calculated for C5 for the different tissues <italic>T</italic> using the Poulin method [<xref ref-type="bibr" rid="R39">39</xref>] (<xref ref-type="supplementary-material" rid="SD2">Table S2 (E)</xref>). Furthermore, we assumed that C5 was only excreted through urine, and not through faeces, since HMDB only listed urine as excreta in the disposition section for C5 (HMDB0000688) [<xref ref-type="bibr" rid="R40">40</xref>]. The renal clearance of acylcarnitines, such as C5, is 4 - 8 times higher than the one of C0 [<xref ref-type="bibr" rid="R51">51</xref>], which is reported to be 1-3 ml/min per adult person [<xref ref-type="bibr" rid="R41">41</xref>]. Taking 2 ml/min and dividing this by the average adult body surface area of 1.73<italic>m</italic><sup>2</sup>, the infantile renal clearance of C0 would be 0.67 ml/min. Hence, the final infantile C5 renal clearance was set to be 4.64 ml/min, which is six times higher than the renal clearance of C0.</p></sec><sec id="S7"><title>Step 3: Defining frequency and time intervals for C5 prediction</title><p id="P18">We defined that we would like to simulate the PBPK model over, e.g., two-hours, with one simulation corresponding to 10 minutes, during which the flux through <inline-formula><mml:math id="M3"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> was assumed to be constant.</p></sec><sec id="S8"><title>Step 4: Coupling of PBPK and infant-WBM models for C5 prediction</title><p id="P19">The setup from Step 3 means that after after ten minutes, the venous and arterial C5 concentration predictions from the PBPK model was used to update the bounds of the corresponding reactions in the infant-WBM (see Step 1 and Method section). Then, the infant-WBM was solved using flux balance analysis (FBA) using the COBRA Toolbox [<xref ref-type="bibr" rid="R16">16</xref>] in MATLAB, while maximising for the whole-body biomass reaction. From the resulting flux vector, we retrieved the flux value for each C5 organ-specific exchange reaction (Step 1, Methods) leading to a <inline-formula><mml:math id="M4"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> for each organ, which were used to update the PBPK model. Then, the ODE’s were solved in MATLAB. This step was repeated 12 times for the two-hour interval, 30 times for the five-hour interval, and 432 times for the 72-hour interval. The initial concentration of C5 was set to 0.1 μmol/l, the healthy average of over 2 million newborns [<xref ref-type="bibr" rid="R52">52</xref>]. This initial concentration was set for all tissues <italic>T</italic>.</p></sec></sec><sec id="S9"><label>3.3</label><title>Dynamic biomarker prediction for infant models</title><sec id="S10"><label>3.3.1</label><title>Dynamic changes of C5 in biofluids and organs</title><p id="P20">To investigate whether the C5-specific dynamic infant-WBMs could be used to predict the time-dependent changes of C5 in the different biofluids and organs, we used the healthy female and male infant models and predicted the C5 concentration in the blood compartment. The predictions over a two-hour interval for the artery, heart, kidney, lung, muscle, and venous blood compartment showed similar behaviours for the organs in the female and the male models (<xref ref-type="fig" rid="F2">Figure 2 (A, B)</xref>). Overall, the C5 concentrations were dynamically increasing or decreasing in the first 30 minutes until they were nearly constant, i.e., they reached a steady state. The female model obtained higher concentration values for the venous (0.38 μmol/l) and lung (0.33 μmol/l) than the male model (venous: 0.31 μmol/l; lung: 0.19 μmol/l) after the two-hour interval (<xref ref-type="fig" rid="F2">Figure 2 (A, B)</xref>). For both models, the C5 concentration in the artery, heart, kidney, and muscle were lower than the initial value 0.1 μmol/l (<xref ref-type="fig" rid="F2">Figure 2 (A, B)</xref>). All of the predicted values in the male and female models were beneath the 99<sup><italic>th</italic></sup> percentile (0.51 μmol/l) of blood C5 concentration used as cut-off values for IVA [<xref ref-type="bibr" rid="R53">53</xref>, <xref ref-type="bibr" rid="R43">43</xref>].</p></sec><sec id="S11"><label>3.3.2</label><title>Simulation of IVA and the predicted C5 concentration</title><p id="P21">To evaluate the consequences of a deficiency in the isovaleryl-CoA dehydrogenase, we derived an IVA model from the healthy model, by setting the bounds of the corresponding reactions in any organ to zero (<xref ref-type="supplementary-material" rid="SD3">Table S3</xref>, see Methods), thereby assuming a complete knockout. In the IMD simulation for IVA, we maximised for C5 accumulation in the blood compartment (i.e., the DM_ivcrn[bc] reaction) in both, the healthy and the IVA model. Over the five hours of prediction time, the healthy (WT) model reached a C5 level of 0.37 μmol/l in the venous compartment (<xref ref-type="fig" rid="F2">Figure 2 (C)</xref>). In contrast, in the IVA model, the C5 predictions in all organs increased continuously with the venous blood compartment having the highest concentration, reaching a level of 0.59 μmol/l after five hours (<xref ref-type="fig" rid="F2">Figure 2 (D)</xref>). This value is higher than the 99<sup><italic>th</italic></sup> percentile (0.51 μmol/l), which has been established in a large-cohort of healthy newborns to be a suitable cutoff for (attenuated) IVA [<xref ref-type="bibr" rid="R53">53</xref>]. Furthermore, the predicted concentration in all other organs was higher in the IVA than in the healthy model, lung (WT: 0.22 μmol/l, IVA: 0.35 μmol/l), heart (WT: 0.04 μmol/l, IVA: 0.06 μmol/l), kidney (WT: 0.04 μmol/, IVA: 0.06 μmol/l, and muscle (WT: 0.02 μmol/l, IVA: 0.04 μmol/l, <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). When predicting C5 concentration in the venous blood compartment over 72 hours, it reached 3.5 μmol/l (<xref ref-type="fig" rid="F2">Figure 2 (E)</xref>) and thus exceeded the 99.99<sup>th</sup> percentile (1.37 μmol/l) of blood C5 concentration, which had been established as a suitable cut-off value for IVA [<xref ref-type="bibr" rid="R53">53</xref>]. This cutoff value was exceeded after 22 hours and is thus elevated during the recommended age for newborn screening in Germany of 36 - 72 hours of life [<xref ref-type="bibr" rid="R54">54</xref>].</p></sec><sec id="S12"><label>3.3.3</label><title>Effect of reduced dietary L-leucine on C5 concentration in IVA models</title><p id="P22">The treatment of IMDs, such as IVA, needs to be individualised depending on age-dependent requirements and disease severity for each patient due to the substantial variability of IMDs [<xref ref-type="bibr" rid="R5">5</xref>]. These treatments include dietary interventions, such as restricting the uptake of metabolites or giving supplements [<xref ref-type="bibr" rid="R55">55</xref>]. Identifying the best treatment strategy for a patient, including the amount of natural food and supplements, is part of the patient-specific diet [<xref ref-type="bibr" rid="R56">56</xref>]. Hence, the possibility to test and evaluate therapies and treatments <italic>in silico</italic> with personalised models could be very beneficial for both patients and clinicians. As a first step to show the impact of dietary interventions on dynamic infant-WBMs, we investigate whether the predicted changes in C5 from the IMD analysis for IVA can be attenuated by dietary changes. For IVA, a study investigating 140 patients with IVA from 39 centres reported that 133 patients (from 38 centres) were given a protein restricted diet supplemented with leucine-free amino acids [<xref ref-type="bibr" rid="R57">57</xref>]. To analyse the effect a reduced dietary L-leucine uptake has on the dynamic model, we reduced the dietary intake of L-leucine in the male infant IVA model by 10% and predicted the C5 concentration over 72 hours. Note that we did not consider any further diet modification, such as carnitine supplementation, which is routinely done [<xref ref-type="bibr" rid="R57">57</xref>]. As expected, the reduction in dietary L-leucine led to a decrease in C5 venous blood concentration over the simulated time period of 72 hours (<xref ref-type="fig" rid="F2">Figure 2 (F)</xref>). After 72 hours, the C5 venous concentration only increased to a value of 2 μmol/l, whereas the untreated dynamic IVA infant-WBM predicted a C5 venous concentration of 3.5 μmol/l (<xref ref-type="fig" rid="F2">Figure 2 (E)</xref>). However, the C5 concentration remained still very high compared to the healthy C5 concentration. Taken together, this example demonstrates that the dynamic infant-WBM can be used for testing the effect of a single dietary change on a biomarker but also that further model refinement is required to reproduce known biomarker dynamics quantitatively.</p></sec></sec><sec id="S13"><label>3.4</label><title>Uncertainty quantification in dynamic infant-WBMs</title><p id="P23">The infant-specific PBPK model of the dynamic infant-WBMs was parametrised with values obtained from the literature, which could introduce uncertainties in the model. Therefore, we performed an uncertainty quantification (UQ) analysis for specific parameters using a Monte Carlo sampling method in the male infant-specific PBPK model [<xref ref-type="bibr" rid="R58">58</xref>]. For the UQ, we only analysed the infant-specific PBPK part of the coupled dynamic infant model, since this made it computationally possible to simulate 100,000 realisations in less than 15 minutes by using the Parallel Computing Toolbox implemented in MATLAB [<xref ref-type="bibr" rid="R59">59</xref>]. By quantifying this uncertainty and its impact on the model’s result, the reliability of the model when confronted with real-world data errors can be estimated. We investigated the following literature-derived parameters: lipophilicity <italic>l</italic>, urinary clearance <italic>cl<sub>urine</sub></italic>, and fractional unbound plasma <inline-formula><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>. Therefore, we applied a Monte Carlo simulation with 100,000 realisations for every parameter and compared 100 randomly selected realisations with line plots to assess the impact of each uncertain parameters over a two-hour interval (<xref ref-type="fig" rid="F3">Figure 3</xref>). In the previous section, the lipophilicity was assumed to be -2 [<xref ref-type="bibr" rid="R40">40</xref>]. The fractional unbound plasma was determined based on experimental studies performed in the literature as <inline-formula><mml:math id="M6"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.933</mml:mn></mml:mrow></mml:math></inline-formula> for all tissues <italic>T</italic> [<xref ref-type="bibr" rid="R49">49</xref>]. The renal clearance of C5 was estimated as 4.64 [<xref ref-type="bibr" rid="R51">51</xref>, <xref ref-type="bibr" rid="R41">41</xref>]. With these parameters fixed, the infant-specific PBPK model predicted a C5 concentration in the venous compartment of 0.356 μmol/l after two hours. For each Monte Carlo evaluation, the parameters that were not randomly sampled were assigned these values.</p><sec id="S14"><label>3.4.1</label><title>Lipophilicity</title><p id="P24">The lipophilicity parameter refers to the capacity of C5 to dissolve in lipids [<xref ref-type="bibr" rid="R50">50</xref>]. The lipophilicity has been predicted as <italic>l</italic> = −2 using ALOGPS (<ext-link ext-link-type="uri" xlink:href="https://vcclab.org/lab/alogps/">https://vcclab.org/lab/alogps/</ext-link>) and <italic>l</italic> = −3 using ChemAxom (<ext-link ext-link-type="uri" xlink:href="https://chemaxon.com/calculators-and-predictors#logp_logd">https://chemaxon.com/calculators-and-predictors#logp_logd</ext-link>) according to the HMDB [<xref ref-type="bibr" rid="R40">40</xref>] (<ext-link ext-link-type="uri" xlink:href="https://hmdb.ca/metabolites/HMDB0000688">https://hmdb.ca/metabolites/HMDB0000688</ext-link>). We applied uniform sampling in the interval <italic>I<sub>l</sub></italic> = [−3, −2] to obtain 100,000 random samples for the lipophilicity parameter <inline-formula><mml:math id="M7"><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mi>l</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mtext> 100, 000</mml:mtext></mml:mrow></mml:math></inline-formula>. These samples were then used as lipophilicity input parameters for the PBPK model to predict the C5 concentration over two hours in the venous compartment. The UQ analysis showed that the mean of the predicted venous concentration was 0.356 μmol/l (range: 0.355 - 0.356 μmol/l, <xref ref-type="fig" rid="F3">Figure 3 (A)</xref>). Although the underlying distribution of the random variables <inline-formula><mml:math id="M8"><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mi>l</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> was uniform, the C5 prediction was negatively skewed, <italic>s</italic> = −0.77, (calculated with <italic>skewness.m</italic> [<xref ref-type="bibr" rid="R59">59</xref>], <xref ref-type="fig" rid="F3">Figure 3 (A)</xref>). Overall, the C5 predictions over two hours of 100 realisations showed minimal variability in the C5 prediction over time due to the variation in the lipophilicity parameter <italic>l</italic> (<xref ref-type="fig" rid="F3">Figure 3 (A)</xref>).</p></sec><sec id="S15"><label>3.4.2</label><title>Urine clearance rate</title><p id="P25">The urine clearance rate <italic>cl<sub>urine</sub></italic> describes the amount of urine excreted by an infant per time unit. The urine clearance rate of C5 was 4-8 times higher than the renal clearance of C0 [<xref ref-type="bibr" rid="R51">51</xref>], estimated as 1.16 ml/min/1.73m<sup>2</sup> [<xref ref-type="bibr" rid="R41">41</xref>]. Consequently, the interval boundaries for the renal clearance were between 4.64 and 9.28, rounded to the interval <italic>I<sub>cl</sub></italic> = [4.5, 9.5]. Uniform sampling in this interval was applied to obtain 100,000 random samples for the renal clearance parameter, which was multiplied by the infant-specific body surface area. The resulting value was used for the renal clearance parameter <inline-formula><mml:math id="M9"><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mtext> 100, 000</mml:mtext></mml:mrow></mml:math></inline-formula> to predict the C5 concentration over two hours in the venous compartment. The mean of the predicted concentration was 0.35 μmol/l, and the values were between 0.34 - 0.38 μmol/l (<xref ref-type="fig" rid="F3">Figure 3 (B)</xref>) with a nearly uniform distribution that had a slight positive skewness, <italic>s</italic> = 0.04. The C5 predictions over two hours of 100 realisations showed that there was some variability in the C5 prediction over time due to the variation in the urine clearance rate <italic>cl<sub>urine</sub></italic> (<xref ref-type="fig" rid="F3">Figure 3 (B)</xref>). For the first 30 minutes, the predictions were very similar for all 100 realisations, and with progressing time, the predictions showed more variability (<xref ref-type="fig" rid="F3">Figure 3 (B)</xref>).</p></sec><sec id="S16"><label>3.4.3</label><title>Fractional unbound plasma</title><p id="P26">The fractional unbound plasma, <inline-formula><mml:math id="M10"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, defines a drug’s binding degree in plasma [<xref ref-type="bibr" rid="R60">60</xref>]. It was determined based on a standard addition experiment and was reported to be <inline-formula><mml:math id="M11"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.908</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M12"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.933</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M13"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1.04</mml:mn></mml:mrow></mml:math></inline-formula> depending on the amount of added compound [<xref ref-type="bibr" rid="R49">49</xref>]. Therefore, uniform sampling was applied in the interval <italic>I<sub>f</sub></italic> = [0.9, 1.05] for 100,000 samples, <inline-formula><mml:math id="M14"><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mn>100</mml:mn><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mn>000</mml:mn></mml:mrow></mml:math></inline-formula>. These samples were then used as fractional unbound plasma input parameters for the PBPK model to predict the C5 concentration over two hours in the venous compartment. The mean of the predicted concentration was 0.25 μmol/l and the values were between 0.09 - 0.47 μmol/l (<xref ref-type="fig" rid="F3">Figure 3 (C)</xref>). Unlike the underlying uniform distribution of the random variables <inline-formula><mml:math id="M15"><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>, the model output <inline-formula><mml:math id="M16"><mml:mrow><mml:mi>P</mml:mi><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>K</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> showed a positive skewness <italic>s</italic> = 0.3. Already starting after 10 minutes of prediction time, the 100 evaluated realisations showed variation in the concentration prediction, which increased with progressing time (<xref ref-type="fig" rid="F3">Figure 3 (C)</xref>).</p></sec><sec id="S17"><label>3.4.4</label><title>Comparison of all uncertain parameters</title><p id="P27">All three investigated parameters, lipophilicity <italic>l</italic>, urinary clearance <italic>cl<sub>urine</sub></italic>, and fractional unbound plasma <inline-formula><mml:math id="M17"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, had uncertainties associated with them based on the methods and literature sources used to determine them. The UQ evaluation showed that the model’s C5 prediction varied in the venous blood compartment, but also in other compartments, depending on the investigated parameter (<xref ref-type="fig" rid="F4">Figure 4 (A)</xref>). The variation in the venous C5 prediction due to the random sampling of the lipophilicity parameter <italic>l</italic> and urine clearance rate <italic>cl<sub>urine</sub></italic> was small compared to the output variation, which was due to the fractional unbound plasma <inline-formula><mml:math id="M18"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> (<xref ref-type="fig" rid="F4">Figure 4 (A)</xref>). The expected mean value of the C5 concentration after two hours was 0.35 μmol/l with the UQ evaluation for the lipophilicity l and for the renal clearance <italic>cl<sub>urine</sub></italic>. In contrast, the expected mean value of the C5 concentration after two hours was considerably lower with the UQ evaluation for <inline-formula><mml:math id="M19"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> (0.25 μmol/l, <xref ref-type="fig" rid="F4">Figure 4 (A)</xref>). Moreover, when comparing the C5 predictions of the same UQ evaluations in the urine, the urine clearance rate <italic>cl<sub>urine</sub></italic> showed the highest impact on the C5 prediction from the three evaluated parameters (<xref ref-type="fig" rid="F4">Figure 4 (B)</xref>). The predicted C5 urine concentration varied between 0.006 - 0.012 μmol/l. The UQ evaluations with the fractional unbound plasma <inline-formula><mml:math id="M20"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> predicted urine C5 concentrations between 0.0058 - 0.01 μmol/l, whereas varying the lipophilicity <italic>l</italic> predicted a C5 concentration of 0.009 μmol/l in the urine (4 (B)).</p></sec><sec id="S18"><label>3.4.5</label><title>Simulations with uncertain parameters</title><p id="P28">The UQ analysis revealed that the value of the fractional unbound plasma <inline-formula><mml:math id="M21"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> had a strong influence on the venous C5 prediction of the infant-specific PBPK model. Hence, we investigated what influence the choice of the fractional unbound plasma value would have on the results of the coupled dynamic infant-WBM model. For the previous evaluation the fractional unbound plasma was assumed to be <inline-formula><mml:math id="M22"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.933</mml:mn></mml:mrow></mml:math></inline-formula>. Therefore, we set the fractional unbound plasma to <inline-formula><mml:math id="M23"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1.05</mml:mn></mml:mrow></mml:math></inline-formula>, which was the upper bound of the sampling interval in the UQ analysis (<xref ref-type="sec" rid="S16">section 3.4.3</xref>). This analysis on the WT and IVA model over a five hour interval as well as the prediction results on the 72-hour interval showed consistent trends as with the estimated parameter (<xref ref-type="fig" rid="F5">Figure 5</xref>) although, as expected, the increase in C5 concentration was not as profound. The WT IMD simulation predicts a venous C5 concentrations after five hours of 0.3 μmol/l with <inline-formula><mml:math id="M24"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1.05</mml:mn></mml:mrow></mml:math></inline-formula>. The IVA model shows a decreased ascent, the C5 prediction in the venous compartment after 5 hours is 0.45 μmol/l (<xref ref-type="fig" rid="F5">Figure 5 (B)</xref>) whereas it was predicted as 0.59 μmol/l with <inline-formula><mml:math id="M25"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.933</mml:mn></mml:mrow></mml:math></inline-formula> (<xref ref-type="fig" rid="F2">Figure 2 (D)</xref>). After 72 hours, the predicted C5 concentration in the venous compartment is 1.02 μmol/l (<xref ref-type="fig" rid="F5">Figure 5 (C)</xref>). Taken together, the choice of the fractional unbound plasma influences the IMD simulations for WT and IVA dynamic infant models but the overall result that the models predict increased C5 levels above the cutoff used by most newborn screening laboratories was not affected.</p></sec></sec></sec><sec id="S19" sec-type="discussion"><label>4</label><title>Discussion</title><p id="P29">We presented the development and application of dynamic infant-WBMs, which are an extension of the whole-body models for infantile metabolism [<xref ref-type="bibr" rid="R12">12</xref>]. The dynamic models incorporate PBPK modelling, which allows overcoming the steady-state assumption inherent to genome-scale metabolic models for selected compounds while expanding PBPK models for overall human metabolism. To illustrate the application of such dynamic infant-WBM, we developed a C5-specific dynamic model, which we used to predict changes in C5 bioavailability over time for the healthy and a disease state. We demonstrated that the dynamic model predicts increased blood concentrations for C5 in the disease state above the cut-off used in newborn screening and that this model could be used to predict dietary-based treatment strategies. As the dynamic infant-WBMs can be personalised based on an individuals parameters, they could enable personalised concentration predictions for known and novel biomarkers of healthy and diseased infant metabolism.</p><p id="P30">For the integration of time dependencies, an existing PBPK model [<xref ref-type="bibr" rid="R18">18</xref>] developed for drug research was utilised and adapted for infant physiology based on measured data [<xref ref-type="bibr" rid="R36">36</xref>] and adult references. In contrast to other dynamic metabolic models, which were based on a generic or cell-based model, such as Recon1 [<xref ref-type="bibr" rid="R29">29</xref>], the integration of a whole-body metabolic model allowed the mapping of organ-specific metabolite concentration predictions from the PBPK model to the constraint-based model. The developed procedure enables a flexible integration of different compartments, which can be selected depending on the investigated metabolite concentration, which allows for a compound-specific adaptation of the dynamic infant-WBM. We demonstrated this feature by developing a C5-specific dynamic infant-WBM that allowed for the prediction of the biomarker C5, including only the organs with C5 blood exchange reactions in the infant-WBMs. However, the reduction of the PBPK model to the overlapping organs and biofluid compartments could make model comparisons between different compounds more difficult, as the PBPK part of the model would be based on different ODEs. Hence, the compound-specific inclusion and exclusion of ODEs into the PBPK model should be evaluated carefully for every use case.</p><p id="P31">For the PBPK coupling, it was assumed that the predicted flux through the infant-WBM did not change every time step and was only updated every ten minutes for computational efficiency. When changing this evaluation interval to shorter intervals, the simulations showed no major differences in the C5 concentration prediction. However, this assumption could be inaccurate in scenarios where a rapid change of the metabolite flux is expected in a short time interval and should be reevaluated for different metabolites.</p><p id="P32">The dynamic infant-WBMs were parametrised with parameters calculated or obtained from experimental results in the literature. These parameters have uncertainties attached to them resulting, for example, from the experimental methods applied to obtain them. Hence, a UQ analysis for three of these parameters was performed to quantify the corresponding uncertainty. The Monte Carlo method highlighted the impact of variations of urinary clearance <italic>cl<sub>urine</sub></italic> and fractional unbound plasma <inline-formula><mml:math id="M26"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> parameters on the predicted C5 concentration over two hours (<xref ref-type="fig" rid="F3">Figure 3</xref>). The fractional unbound plasma <inline-formula><mml:math id="M27"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> showed large variations in the blood C5 concentration with a mean of 0.25 μmol/l, which was considerably lower than the mean values (0.35 μmol/l) when the fractional unbound plasma was not varied. Consequently, it should be ensured that the fractional unbound plasma <inline-formula><mml:math id="M28"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> used in the dynamic infant-WBM is estimated correctly, as this parameter strongly impacts the output of the model. Similarly, the comparison between the C5 predictions in the urine compartment showed that variations in the urine clearance rate parameters have the strongest impact on the predicted concentration (<xref ref-type="fig" rid="F3">Figure 3</xref>) and thus, this parameter should also be estimated correctly. Overall, the UQ analysis highlighted the importance of quantifying parameter uncertainties in mathematical models, such as the dynamic infant-WBMs, and that any conclusions derived from these simulations should consider the assumed parameters in the model.</p><p id="P33">The IMD research is evolving from a ’static’ view of simple pathways towards a ’dynamic’ view of metabolic fluxes [<xref ref-type="bibr" rid="R5">5</xref>]. Hence, we demonstrated how the dynamic infant-WBMs can enable a simulation of the dynamic behaviours of infant metabolism. We predicted the concentration changes of the clinically relevant biomarker C5 for isovaleric aciduria (IVA) in the healthy dynamic-infant WBMs, which reached steady state within the simulated two hour interval (<xref ref-type="fig" rid="F2">Figure 2</xref>). Importantly, the predicted values (female: venous (0.38 μmol/l), lung (0.33 μmol/l; male model: venous: 0.31 μmol/l; lung: 0.19 μmol/l) remained below the 99<sup><italic>th</italic></sup> percentile cut-off value (0.51 μmol/l) used in clinical practice for IVA [<xref ref-type="bibr" rid="R53">53</xref>] throughout the simulation time period. In contrast, in the dynamic infant-WBMs for IVA, in which we assumed no flux through the reactions associated with the genetic defect, the C5 concentration was seven times higher (i.e., 3.5 μmol/l, <xref ref-type="fig" rid="F2">Figure 2</xref>) throughout the recommended age for newborn screening in Germany at 36 - 72 h of life [<xref ref-type="bibr" rid="R54">54</xref>]. However, these cutoff values represent only a guidance for further biochemical and genetic testing. In one large-scale study, individuals with attenuated IVA had a median C5 value of 2.6 μmol/l (range: 0.7 - 6.4 μmol/l) and individuals with classic IVA of 10.6 μmol/l (range: 4.3 - 21.7 μmol/l) [<xref ref-type="bibr" rid="R42">42</xref>]. In another study, the mean and standard deviation of C5 concentrations in newborns with attenuated IVA (n=22) was 2.6±1.16 μmol/l, whereas for severe patients with classic IVA it was 12.6±5.22 μmol/l [<xref ref-type="bibr" rid="R52">52</xref>]. A further study showed that C5 concentrations in dried blood spots above the cut-off of 5.6 μmol/l could be associated with a symptomatic classic IVA disease course with metabolic decompensations and an in trend inversely correlated IQ [<xref ref-type="bibr" rid="R43">43</xref>]. While the ranges of C5 in newborns with attenuated and classic IVA varied, they were all higher than our predictions after 72 hours. This highlights the difficulty of interpreting the dynamic infant-WBMs quantitatively. Moreover, as the UQ analysis showed, critical model parameters need to be either experimentally determined or multiple estimation approaches should be used to certify their values. These parameter uncertainties could possibly explain the discrepancy between the predicted and expected C5 concentrations. Nonetheless, our example demonstrated the potential use of the dynamic infant-WBMs for the qualitative prediction of C5 biomarker dynamics and how the developed procedure could be easily applied to other biomarkers and other IMDs associated with newborn screening.</p><p id="P34">The ability of infant-WBMs to predict the effect of dietary interventions on an IMD model has already been demonstrated [<xref ref-type="bibr" rid="R12">12</xref>]. This kind of treatment analysis needs to be patient-specific since the disease therapy and dietary guidelines for IMD patients have to be adapted to age-dependent requirements and the patient’s disease severity [<xref ref-type="bibr" rid="R5">5</xref>]. Here, personalised infant-WBMs can account for the substantial variability in patients since their treatment has to be individualised based on the patient’s diagnosis and clinical phenotype [<xref ref-type="bibr" rid="R5">5</xref>]. In this study, we showed that a reduction of dietary leucine decreased the C5 prediction in the IVA model. It should be noted that in our proof-of-principle, we could not decrease the dietary leucine intake below 10% of the normal infant diet applied as leucine is an essential amino acid and the model did not account for the infantile gut microbiota. In adult men, the microbial contribution to host leucine levels has been estimate to be between 24–27% of the estimated average requirement [<xref ref-type="bibr" rid="R61">61</xref>]. Expanding the dynamic infant-WBM to the gut microbial metabolic activity would be a valuable next step. The integration of personalised microbial community models with WBMs has been already demonstrated for the adult WBMs [<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R62">62</xref>, <xref ref-type="bibr" rid="R63">63</xref>]. By progressing to dynamic infant-WBMs, and potentially even including gut microbial metabolism, would enable <italic>in silico</italic> predictions of short-term metabolic responses of an individual’s metabolism to the diet intake. By this, the models could support clinicians in personalised treatment planning and therapy for IMDs.</p><p id="P35">Moreover, the developed framework could be used for modelling pharmacokinetics and pharmacodynamics of drugs specifically for infants as these processes are often different from adults [<xref ref-type="bibr" rid="R64">64</xref>, <xref ref-type="bibr" rid="R65">65</xref>]. This could allow for infant-specific drug dosage determination, which enables to account for the infant’s immature drug metabolism that is often associated with drug toxicity [<xref ref-type="bibr" rid="R66">66</xref>]. This is important since almost 50% of prescription drugs lack age-appropriate dosing guidelines [<xref ref-type="bibr" rid="R66">66</xref>]. Additionally, paediatric drug clearance data is less attainable, which is probably due to the difficulties associated with conducting paediatric clinical trials [<xref ref-type="bibr" rid="R67">67</xref>, <xref ref-type="bibr" rid="R68">68</xref>]. Hence, analysing these drug-related metabolic processes in <italic>silico</italic> could be very beneficial for researchers, clinicians, and patients.</p><p id="P36">These results illustrate the great potential of dynamic infant-WBMs to predict temporal changes in known and novel biomarkers for IMDs. However, any <italic>in silico</italic> predictions need to be validated against experimental data and by clinical experts. In the case of the fractional unbound plasma, different modelling methods have been developed [<xref ref-type="bibr" rid="R69">69</xref>, <xref ref-type="bibr" rid="R70">70</xref>, <xref ref-type="bibr" rid="R71">71</xref>], which could provide more reliable values for this critical parameter. Furthermore, obtaining all the data necessary to personalise the dynamic infant-WBMs from one individual would allow for an improved personalisation of the dynamic infant-WBMs. Additional data, especially measurements from infants over several time intervals, are essential to enhance model validation and would contribute to the model’s reliability and applicability. In future studies, applying personalised data from patients with IMDs could be a next step to obtain quantitatively correct metabolite concentration prediction.</p><p id="P37">In conclusion, the dynamic infant-WBMs showcased the potential of coupling PBPK and infant-WBM models, opening new research directions for dynamic evaluations of infant metabolism. This capability holds significance for future infant-specific drug research and dietary treatment planning, where understanding the dynamic development of metabolite concentrations and the metabolic response to dietary interventions over time is crucial.</p></sec><sec id="S20" sec-type="methods"><label>5</label><title>Methods</title><sec id="S21"><label>5.1</label><title>Physiological-based pharmacokinetic modelling</title><p id="P38">Physiological-based pharmacokinetic (PBPK) models extend Pharmacokinetic (PK) models, which are used to understand drugs and their distribution in an organism following an intravenous or oral dosing [<xref ref-type="bibr" rid="R35">35</xref>]. PK models describe the change of drug concentration <italic>C</italic> over time <italic>t</italic> depending on the drug clearance <italic>Cl</italic>, which describes the volume of plasma or blood that is cleared of the drug per unit time (l/min) and the volume of distribution <italic>V</italic>, which is the volume of the organ or tissue a drug distributes into [<xref ref-type="bibr" rid="R72">72</xref>], <disp-formula id="FD2"><label>(1)</label><mml:math id="M29"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow><mml:mi>V</mml:mi></mml:mfrac><mml:mo>⋅</mml:mo><mml:mi>C</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P39">PBPK models enable the integration of various physiological parameters into this PK framework by adding compartments that correspond to different organs and tissues in the human body [<xref ref-type="bibr" rid="R35">35</xref>]. In the following, the term tissue <italic>T</italic> will be used for all organs and compartments of the human body considered in the PBPK models, such as organs or blood compartments. The tissues <italic>T</italic> are connected through the blood exchange in both venous and arterial blood. The arterial blood is the oxygenated blood, which is transported to all organs, except the lung (<xref ref-type="fig" rid="F6">Figure 6</xref>). The venous blood is the deoxygenated blood, which leaves the organs and is pumped back into the lungs for oxygen uptake (<xref ref-type="fig" rid="F6">Figure 6</xref>). For each tissue <italic>T</italic>, except for the lung, the rate of concentration change over time <italic>t</italic> of a compound <italic>C<sub>T</sub></italic> is described by the arterial inflow concentration <italic>C<sub>a</sub></italic> and the tissue-specific venous outflow concentration <italic>C<sub>v<sub>T</sub></sub></italic>, <disp-formula id="FD3"><label>(2)</label><mml:math id="M30"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula> where <italic>V<sub>T</sub></italic> is the tissue volume (l), <italic>Q<sub>T</sub></italic> is the blood flow (1/h), and <inline-formula><mml:math id="M31"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:mi>B</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula> is the venous outflow concentration with <italic>K<sub>T</sub></italic> the tissue partition coefficient and <italic>B</italic> the blood-to-plasma ratio. The blood-to-plasma ratio is used to correct for blood when the plasma is used to determine the pharmacokinetic parameters, although the blood should be the true central compartment [<xref ref-type="bibr" rid="R73">73</xref>]. Based on this, the generic ordinary differential equation (ODE) of the rate concentration <italic>C<sub>T</sub></italic> in a tissue <italic>T</italic> that is changing over time <italic>t</italic> can be written as <disp-formula id="FD4"><label>(3)</label><mml:math id="M32"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>⋅</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P40">Different approaches, such as perfusion rate-limited kinetics and permeability rate-limited kinetics, are used to model the kinetics within the compartments. In our work, all processes are modelled with perfusion rate-limited kinetics since it often occurs for small lipophilic molecules, which can dissolve easier in lipids than in water [<xref ref-type="bibr" rid="R35">35</xref>]. For these molecules, the blood flow to the tissue becomes the limiting process [<xref ref-type="bibr" rid="R35">35</xref>]. In perfusion rate-limited kinetics, it is assumed that tissue membranes do not impede diffusion. At steady state, the rate of drug entry into a compartment equals the product of the organ’s blood flow rate and the incoming blood concentration. The total drug concentration in a tissue <italic>T</italic> is in equilibrium with the concentration in the circulation as governed by the drug-specific tissue partition coefficient <italic>K<sub>T</sub></italic> [<xref ref-type="bibr" rid="R35">35</xref>]. The time to reach a steady state is determined by <italic>K<sub>T</sub></italic>, the blood flow rate <italic>Q<sub>T</sub></italic>, and the tissue volume <italic>VT</italic> [<xref ref-type="bibr" rid="R35">35</xref>]. There are several methods to estimate the tissue partition coefficient <italic>K<sub>T</sub></italic>. In this study, the Poulin method is applied [<xref ref-type="bibr" rid="R39">39</xref>], which assumes that the compound distributes homogeneously into the tissue and plasma by passive diffusion [<xref ref-type="bibr" rid="R35">35</xref>]. Based on the Poulin method [<xref ref-type="bibr" rid="R39">39</xref>], the tissue partition coefficient <italic>K<sub>T</sub></italic> of a tissue <italic>T</italic> can then be determined as, <disp-formula id="FD5"><label>(4)</label><mml:math id="M33"><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mo>(</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mn>0.3</mml:mn><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mi>w</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:mn>0.7</mml:mn><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mo>(</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mn>0.3</mml:mn><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mi>w</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:mn>0.7</mml:mn><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>T</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P41">where <italic>l</italic> is the lipophilicity, referring to the capacity of a chemical compound to dissolve in lipids, <inline-formula><mml:math id="M34"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M35"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> are the specific volume fractions of neutral lipid, <inline-formula><mml:math id="M36"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M37"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> are the specific volume fractions of phospholipid, and <inline-formula><mml:math id="M38"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>T</mml:mi><mml:mi>w</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M39"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>p</mml:mi><mml:mi>w</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> are the specific volume fractions of water in tissue <italic>T</italic> and plasma <italic>p</italic>, respectively [<xref ref-type="bibr" rid="R50">50</xref>]. All these volumes can be obtained from literature [<xref ref-type="bibr" rid="R50">50</xref>]. Furthermore, the chemical bind in plasma or fractional unbound plasma <inline-formula><mml:math id="M40"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> defines a drug’s binding degree in plasma [<xref ref-type="bibr" rid="R60">60</xref>]. This fraction describes the fraction of the compound that is not bound to plasma proteins and free for interaction with receptors, metabolizing enzymes, and renal filtration [<xref ref-type="bibr" rid="R73">73</xref>]. The compound-specific values for <inline-formula><mml:math id="M41"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> can be obtained from experimental results in literature [<xref ref-type="bibr" rid="R74">74</xref>] and applied to calculate the chemical bind in tissue, <inline-formula><mml:math id="M42"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>T</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>, with <disp-formula id="FD6"><label>(5)</label><mml:math id="M43"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>T</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P42">In addition to the tissue-specific models described by <xref ref-type="disp-formula" rid="FD4">Eq. (3)</xref>, the PBPK model incorporates additional equations for the arterial and venous blood compartment, as well as for the renal and bile excretion. The arterial and venous blood compartments connect all the tissue-specific ODEs (<xref ref-type="fig" rid="F6">Figure (6)</xref>).</p></sec><sec id="S22"><label>5.2</label><title>PBPK model used for the dynamic infant-WBMs</title><p id="P43">We used an existing PBPK model [<xref ref-type="bibr" rid="R18">18</xref>], which describes the dynamics of a system with 23 ODEs. For each compound of interest <italic>i</italic>, the time-dependent concentration in a specific tissue, such as adipose tissue, brain, small intestine, large intestine, heart, kidney, liver, lung, muscle, pancreas, skin, spleen, stomach, and bone, was calculated. Additionally, this PBPK model contained auxiliary ODEs to describe the transit from bile to small and large intestine lumen as well as separate equations for renal and bile clearance. For a compound <italic>i</italic> (a metabolite or drug), the applied PBPK model contains the following system of equations:</p><p id="P44"><bold>Adipose tissue</bold><disp-formula id="FD7"><label>(6)</label><mml:math id="M44"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P45"><bold>Artery blood</bold><disp-formula id="FD8"><label>(7)</label><mml:math id="M45"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p id="P46"><bold>Brain</bold><disp-formula id="FD9"><label>(8)</label><mml:math id="M46"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P47"><bold>Small intestine</bold><disp-formula id="FD10"><label>(9)</label><mml:math id="M47"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P48"><bold>Large Intestine</bold><disp-formula id="FD11"><label>(10)</label><mml:math id="M48"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mi>k</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p id="P49"><bold>Heart</bold><disp-formula id="FD12"><label>(11)</label><mml:math id="M49"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P50"><bold>Kidney</bold><disp-formula id="FD13"><label>(12)</label><mml:math id="M50"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p id="P51"><bold>Liver</bold><disp-formula id="FD14"><label>(13)</label><mml:math id="M51"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="FD15"><label>(14)</label><mml:math id="M52"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p id="P52"><bold>Lung</bold><disp-formula id="FD16"><label>(15)</label><mml:math id="M53"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P53"><bold>Muscle</bold><disp-formula id="FD17"><label>(16)</label><mml:math id="M54"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P54"><bold>Pancreas</bold><disp-formula id="FD18"><label>(17)</label><mml:math id="M55"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P55"><bold>Skin</bold><disp-formula id="FD19"><label>(18)</label><mml:math id="M56"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P56"><bold>Spleen</bold><disp-formula id="FD20"><label>(19)</label><mml:math id="M57"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P57"><bold>Stomach</bold><disp-formula id="FD21"><label>(20)</label><mml:math id="M58"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P58"><bold>Bone</bold><disp-formula id="FD22"><label>(21)</label><mml:math id="M59"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P59"><bold>Venous</bold><disp-formula id="FD23"><label>(22)</label><mml:math id="M60"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p id="P60"><bold>Transit from bile to small intestine lumen</bold><disp-formula id="FD24"><label>(23)</label><mml:math id="M61"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mi>k</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula><disp-formula id="FD25"><label>(24)</label><mml:math id="M62"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>k</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula><disp-formula id="FD26"><label>(25)</label><mml:math id="M63"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>k</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p id="P61"><bold>Small intestine lumen</bold><disp-formula id="FD27"><label>(26)</label><mml:math id="M64"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>k</mml:mi><mml:mi>L</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p id="P62"><bold>Large intestine lumen</bold><disp-formula id="FD28"><label>(27)</label><mml:math id="M65"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mi>L</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>k</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:msub><mml:mi>al</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p id="P63"><bold>Urine</bold><disp-formula id="FD29"><label>(28)</label><mml:math id="M66"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p id="P64"><bold>Faeces</bold><disp-formula id="FD30"><label>(29)</label><mml:math id="M67"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mi>I</mml:mi><mml:msub><mml:mi>L</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p id="P65">Here, <italic>C<sub>T,i</sub></italic> represents the concentration of the compound <italic>i</italic> in a specific tissue <italic>T, V<sub>T</sub></italic> is the tissue volume, <italic>Q<sub>T</sub></italic> the blood flow rate, and <italic>K<sub>T,i</sub></italic> the calculated organ-specific tissue partition coefficient (<xref ref-type="disp-formula" rid="FD5">Eq. 4</xref>) for the compound <italic>i</italic>. Furthermore, <italic>cl<sub>urine,i</sub></italic> and <italic>cl<sub>bile,i</sub></italic> present renal and bile clearance for a specific compound, which are set to zero if the compound cannot be found in the urine or faeces, respectively. The compound-specific constants <italic>ka<sub>i</sub>, kbile<sub>i</sub>, kfecal<sub>i</sub></italic>, and <italic>kLI<sub>i</sub></italic> are the large intestine, bile, and faeces coefficients, which are set to zero if the compound cannot be found in the faeces. This system of equations can then be solved by a commercial ode solver, such as the <monospace>ode45s.m</monospace> function in MATLAB [<xref ref-type="bibr" rid="R59">59</xref>].</p></sec><sec id="S23"><label>5.3</label><title>Whole-body models for infants (infant-WBM)</title><p id="P66">The virtual metabolic human identifiers (VMH IDs) referred to in this study represent the reaction names of the corresponding organ-specific reactions in the infant-WBM models. The non-organ-specific part of the VMH ID can be searched in the VMH database (<ext-link ext-link-type="uri" xlink:href="https://www.vmh.life">https://www.vmh.life</ext-link>) for further information. The metabolic whole-body models for infants (infant-WBM) [<xref ref-type="bibr" rid="R12">12</xref>] present a resource of sex-specific, organ-resolved whole-body models of infant metabolism spanning the first 180 days of life. For the creation of these models detailed knowledge of infants’ physiology, metabolic processes, and newborn screening data was used. They account for organ-specific parameters and included in detail the energy demand for brain development, heart function, muscular activity, and thermoregulation. The models represent active infant metabolism and predict infant growth between zero and six months in agreement with growth trajectories by the WHO [<xref ref-type="bibr" rid="R13">13</xref>]. In this study, a male and female infant-WBM at age one day were used from the metabolic whole-body models for infants (infant-WBM), resource (<ext-link ext-link-type="uri" xlink:href="https://www.vmh.life/files/Newborns/">https://www.vmh.life/files/Newborns/</ext-link>) [<xref ref-type="bibr" rid="R12">12</xref>]. The male infant-WBM has a weight of 3.3 kg, a predicted growth rate at day one of 0.0089%, and was fed 122 ml of breast milk on that day. The female infant-WBM has a weight of 3.2 kg, a predicted growth rate of 0.0075%, and was also fed 122 ml of breast milk. All physiological and nutritional parameters of both models are presented in <xref ref-type="supplementary-material" rid="SD4">Table S4</xref>.</p><sec id="S24"><label>5.3.1</label><title>Flux balance analysis</title><p id="P67">For the flux balance analysis (FBA), the hypergraph of a metabolic network is converted into a stoichiometric matrix <inline-formula><mml:math id="M68"><mml:mrow><mml:mi>S</mml:mi><mml:mo>∈</mml:mo><mml:msup><mml:mi>ℝ</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>×</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>, where the rows correspond to the <italic>m</italic> metabolites and the columns to the <italic>n</italic> reactions. Each matrix entry <italic>S<sub>ij</sub></italic> corresponds to a stoichiometric coefficient, which indicates if and how metabolite <italic>i</italic> takes part in reaction <italic>j</italic>. The change of a metabolite concentration <italic>x<sub>k</sub></italic> over time <italic>t</italic> is then represented by the <italic>k<sup>th</sup></italic> row, while the computed flux value <italic>v<sub>i</sub></italic> corresponds to the <italic>i<sup>th</sup></italic> entry in the flux vector <italic>v</italic> = (<italic>v</italic><sub>1</sub>, …, <italic>v<sub>n</sub></italic>)<sup><italic>T</italic></sup>. Resulting in the mass-balance equation for all metabolites as <disp-formula id="FD31"><label>(30)</label><mml:math id="M69"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mo>⋅</mml:mo><mml:mi>v</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P68">In this study, we use the COBRA approach [<xref ref-type="bibr" rid="R14">14</xref>], which assumes the simulated system to be at a steady state and, hence, <disp-formula id="FD32"><label>(31)</label><mml:math id="M70"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mo>⋅</mml:mo><mml:mi>v</mml:mi><mml:mover><mml:mo>=</mml:mo><mml:mo>!</mml:mo></mml:mover><mml:mn>0.</mml:mn></mml:mrow></mml:math></disp-formula></p><p id="P69">This linear system of equations is then used as constraints in flux balance analysis (FBA) [<xref ref-type="bibr" rid="R15">15</xref>], which is a mathematical approach to minimise or maximise an objective function, e.g., biomass yield, through the metabolic network defining the following linear program (LP), <disp-formula id="FD33"><label>(32)</label><mml:math id="M71"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mi>v</mml:mi></mml:munder></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msup><mml:mi>c</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mo>⋅</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>s</mml:mi><mml:mo>.</mml:mo><mml:mi>t</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>S</mml:mi><mml:mo>⋅</mml:mo><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>l</mml:mi><mml:mi>b</mml:mi><mml:mo>≤</mml:mo><mml:mi>v</mml:mi><mml:mo>≤</mml:mo><mml:mi>u</mml:mi><mml:mi>b</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula> where <italic>lb</italic> and <italic>ub</italic> are the lower and upper bounds on the flux vector <italic>v</italic>. These bounds are based on specific data, such as physiochemical constraints, nutrient uptake rates, and enzyme reaction rates. The vector <italic>c</italic> is a vector of weights indicating which and how much each reaction <italic>i</italic> contributes to the objective function [<xref ref-type="bibr" rid="R15">15</xref>]. By definition, the lower bound on an irreversible reaction was set to <italic>lb</italic> = 0 mmol/day/person and ub &gt; 0 mmol/day/person [<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R11">11</xref>]. For reversible reactions, negative flux through the reactions was allowed, <italic>lb</italic> &lt; 0 mmol/day/person and the upper bound was set to <italic>ub</italic> &gt; 0 mmol/day/person. The <italic>lb</italic> and <italic>ub</italic> of unconstrained reactions were set to the arbitrary values -1,000,000 mmol/day/person and 1,000,000 mmol/day/person, respectively.</p></sec></sec><sec id="S25"><label>5.4</label><title>Four-step procedure for coupling PBPK models and infant-WBMs</title><p id="P70">For the coupling of PBPK models and infant-WBMs, we developed a four-step procedure that can be applied to any metabolite biomarker of interest, such as C5. Overall, the flux through a metabolic reaction in the infant-WBM was interpreted as the intrinsic ability of a compound to be metabolised by the relevant enzyme. Hence, the flux was used to update the PBPK model for predicting the metabolite concentration (<xref ref-type="fig" rid="F1">Figure 1</xref>). Likewise, the predicted metabolite concentrations were used to update the bounds on the flux values in the infant-WBM. This led to an iterative scheme, where both models were evaluated one after the other, and the predictions were used to update the models. This iterative scheme allows to combine information from physiology, pharmacokinetics, and metabolism. The following four steps describe the coupling of both models leading to time-dependent infant-WBMs.</p><sec id="S26"><label>5.4.1</label><title>Step 1. PBPK adaptations for infant physiology</title><p id="P71">First, a PBPK model [<xref ref-type="bibr" rid="R44">44</xref>] is adapted for specific physiological parameters corresponding to an individual. These parameters are extracted from the individual parameters variable of the infant-WBM. Similar to Toroghi et al [<xref ref-type="bibr" rid="R29">29</xref>], the physiological and physicochemical properties in the PBPK model are assumed to be constant over time. In particular, the PBPK parameters for the body mass, organ volumes, and organ flow rates are obtained directly from the infant-WBM models. The calculation of the organ volumes is based on the organ weights reported in the infant-WBM and the respective organ density obtained from literature [<xref ref-type="bibr" rid="R36">36</xref>]. The venous and arterial blood volume estimations are based on the total blood volume resulting in 144 ml of blood in both compartments for a 3.3 kg newborn at day 1 (total blood volume: 288 ml). This is comparable to the blood range of newborns at 72 hours of age (75 to 107 ml/kg) ranging between 248 - 353 ml for a 3.3 kg infant [<xref ref-type="bibr" rid="R47">47</xref>].</p><p id="P72">The organ flow rates are obtained from the organ flow rate parameters of the infant-WBM, which are measured in l/min/kg tissue and converted to l/h/organ. The blood flow rate for venous and arterial blood is estimated as 3 l/h since the blood flow rate ranges from 10 to 50 ml/min in infants weighing less than 5 kg [<xref ref-type="bibr" rid="R38">38</xref>], leading to an estimation of 0.6 - 3 l/h by multiplication with 60/1000. The body surface area is calculated based on the Mosteller method [<xref ref-type="bibr" rid="R48">48</xref>], using the average height of 50 cm for male and 49 cm for female newborns [<xref ref-type="bibr" rid="R37">37</xref>].</p></sec><sec id="S27"><label>5.4.2</label><title>Step 2. Defining compound-specific parameters</title><p id="P73">In the second step, the compound-specific parameters are set. A compound of interest can be a drug or a biomarker, such as an amino acid or acylcarnitine. All processes are modelled with perfusion rate-limited kinetics, and the Poulin method [<xref ref-type="bibr" rid="R39">39</xref>] is used to calculate the tissue partition coefficient <italic>K<sub>t</sub></italic>, <xref ref-type="sec" rid="S21">section 5.1</xref>. For every compound, the molecular weight, lipophilicity l, and fractional unbound plasma <inline-formula><mml:math id="M72"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> have to be determined. The molecular weight and lipophilicity <italic>l</italic> are obtained from databases, such as HMDB [<xref ref-type="bibr" rid="R40">40</xref>]. The fractional unbound plasma <inline-formula><mml:math id="M73"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> can be measured experimentally for amino acids [<xref ref-type="bibr" rid="R74">74</xref>] and acylcarnitines [<xref ref-type="bibr" rid="R49">49</xref>] evaluating the recovery rate, which is obtained by comparing results before and after spiking with known concentrations of standards in plasma [<xref ref-type="bibr" rid="R49">49</xref>]. Furthermore, the renal and bile clearance rate (l/h) is extracted from the literature for amino acids [<xref ref-type="bibr" rid="R75">75</xref>] and L-carnitine [<xref ref-type="bibr" rid="R41">41</xref>]. To account for the consumption and production rate of a compound in an organ, <italic>R<sub>organ</sub></italic>, which is characterized by the Michaelis-Menten kinetics, <disp-formula id="FD34"><label>(33)</label><mml:math id="M74"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula> is subtracted in each organ of the PBPK model [<xref ref-type="bibr" rid="R29">29</xref>, <xref ref-type="bibr" rid="R24">24</xref>]. It is defined by, the compound concentration <italic>C<sub>organ</sub></italic> in a specific organ, <italic>V<sub>max</sub></italic> the maximum velocity of the compound-producing reaction, when all the enzyme’s active sites are saturated with substrate, and <italic>K<sub>m</sub></italic> the Michaelis-Menten constant for the compound [<xref ref-type="bibr" rid="R24">24</xref>].</p></sec><sec id="S28"><label>5.4.3</label><title>Step 3. Time-dependent model parameters</title><p id="P74">To integrate time dependency into the models, the length of the total time intervals and the time intervals calculated by the ODE solver have to be defined. Furthermore, the frequency of the update of the infant-WBM to the ODE model has to be determined. The ODE system of equations can be solved with the <monospace>ode45s.m</monospace> function in MATLAB [<xref ref-type="bibr" rid="R59">59</xref>, <xref ref-type="bibr" rid="R76">76</xref>].</p></sec><sec id="S29"><label>5.4.4</label><title>Step 4. Iterative integration of PBPK and infant-WBM</title><p id="P75">Steps 1. - 3. assemble an infant-specific PBPK model for a specific compound of interest. To integrate the infant-WBM and the PBPK model, the latter is iteratively updated using flux predictions from the infant-WBM, which in turn is revised based on the predicted metabolite concentrations from the PBPK model. This integration is detailed in the following sub-steps.</p><sec id="S30"><title>Step 4.1 Set initial values for compound concentrations in organs</title><p id="P76">The initial value of the compound concentration of interest is set to a published blood concentration measurement of this compound. This value is set for the concentration in every organ and compartment that has an exchange reaction from the organ to the blood compartment (VMH ID: ’EX_<italic>compound</italic>_[bc]’). Additionally, the concentration of the artery and venous blood compartment is set to the initial concentration. The ODEs representing the renal and bile clearance are added to the PBPK model depending on the excretion of the compound of interest. All other tissue-specific ODEs from the full PBPK model are excluded from the compound-specific PBPK model.</p></sec><sec id="S31"><title>Step 4.2 Compute metabolite concentration with PBPK model</title><p id="P77">The PBPK model computes the metabolite concentration for a set time frame. Hence, a dynamic concentration prediction on the PBPK model assembled in steps 1-3 is solved with the ode45s solver implemented in MATLAB [<xref ref-type="bibr" rid="R76">76</xref>, <xref ref-type="bibr" rid="R59">59</xref>].</p></sec><sec id="S32"><title>Step 4.3 Update bounds of infant-WBM with PBPK prediction</title><p id="P78">After the ODE time interval, the predicted metabolite concentration (in mmol/l) is utilised to update the infant-WBM bounds. Therefore, the predicted blood concentrations <italic>C<sub>art</sub>, C<sub>ven</sub></italic> are used to set the lower bounds on the uptake flux <italic>lb<sub>organ</sub></italic> of the compound from the blood circulation into individual organs utilising the organ-specific plasma flow rate (<italic>PFR<sub>organ</sub></italic>). <disp-formula id="FD35"><mml:math id="M75"><mml:mrow><mml:mi>P</mml:mi><mml:mi>F</mml:mi><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mi>B</mml:mi><mml:mo>⋅</mml:mo><mml:mi>C</mml:mi><mml:mi>O</mml:mi><mml:mo>⋅</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>h</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula> where <italic>B</italic> is the organ-specific blood flow rate, <italic>CO</italic> is the cardiac output and <italic>h</italic> is the hematocrit value. For the lung, the venous compound concentration is used since it transports blood from the organs to the lung <disp-formula id="FD36"><label>(34)</label><mml:math id="M76"><mml:mrow><mml:mi>l</mml:mi><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo><mml:mo>⋅</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>1000</mml:mn></mml:mrow></mml:mfrac><mml:mo>⋅</mml:mo><mml:mi>P</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mfrac><mml:mrow><mml:mn>60</mml:mn><mml:mo>⋅</mml:mo><mml:mn>24</mml:mn></mml:mrow><mml:mrow><mml:mn>1000</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula> given in mmol/day/person. For all other organs, the artery compound concentration is applied since the arterial blood is the oxygenated blood transporting oxygen from the lungs to the organs. <disp-formula id="FD37"><label>(35)</label><mml:math id="M77"><mml:mrow><mml:mi>l</mml:mi><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo><mml:mo>⋅</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>1000</mml:mn></mml:mrow></mml:mfrac><mml:mo>⋅</mml:mo><mml:mi>P</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mfrac><mml:mrow><mml:mn>60</mml:mn><mml:mo>⋅</mml:mo><mml:mn>24</mml:mn></mml:mrow><mml:mrow><mml:mn>1000</mml:mn></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P79">By restricting the lower bound of the reactions, the uptake of the biomarker from the respective blood compartment into the organ is restricted.</p></sec><sec id="S33"><title>Step 4.4 Run infant-WBM LP optimisation</title><p id="P80">After step 4.3, the infant-WBM is updated based on the PBPK model and can be evaluated. The whole-body biomass reaction is set to the maximal growth rate of the infant on the day. Then, the LP for the infant-WBM is solved, minimizing the fluxes while adhering to all constraints to obtain a flux <italic>V<sub>j</sub></italic> for each reaction <italic>j</italic> in the network.</p></sec><sec id="S34"><title>Step 4.5 Update PBPK model with infant-WBM flux prediction</title><p id="P81">From the LP solution, the predicted flux <italic>v</italic> through the exchange reaction of the compound are extracted. First, these fluxes are computed in the unit mmol/person/day and then converted to mmol/volume/second. Second, the resulting value is divided by the respective organ volume, as the concentration change over time in the PBPK model is given per organ volume. By this, the converted flux <inline-formula><mml:math id="M78"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> for each organ and the respective excretion pathway is obtained which is used to update the PBPK model. Therefore, the flux is subtracted in the ODE representing the compound in each organ, <disp-formula id="FD38"><label>(36)</label><mml:math id="M79"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>v</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p id="P82">Then, the evaluation starts again at step 4.1.</p></sec></sec></sec><sec id="S35"><label>5.5</label><title>IMD analysis for dynamic infant-WBMs</title><p id="P83">The IMD analysis is utilised in metabolic modelling to demonstrate the human metabolic model’s capability to predict known biomarkers. IMDs often disrupt the normal metabolite flux. Hence, analysing the metabolic flux over time is more informative for IMDs than the static measurement of metabolites at a single time point [<xref ref-type="bibr" rid="R5">5</xref>]. In this work, we used the IMD analysis method for whole-body models, established in Thiele et al [<xref ref-type="bibr" rid="R11">11</xref>], which is a two-step process. In the first step, all reactions <italic>k</italic> = (<italic>k</italic><sub>1</sub>, …, <italic>k<sub>n</sub></italic>)<sup><italic>T</italic></sup> in all model organs associated with the defect gene that causes the IMD are identified. The contribution of these reactions <italic>k<sub>i</sub></italic> is then summed in an artificial reaction <italic>v<sub>d</sub></italic>. This reaction is added to the model, and a first LP is solved, maximizing <italic>v<sub>d</sub></italic>. In the second step, 75% of the optimal solution <italic>z</italic>* is used as a lower bound on <italic>v<sub>d</sub></italic> in the wild type (WT) model. And in the IMD model the flux <italic>v<sub>k</sub></italic> through the <italic>k</italic> associated disease reactions is set to zero. Second, for both models, an artificial demand reaction in the blood compartment <italic>v<sub>D</sub></italic> is set as objective function for flux maximization. The LP of the WT model can be written as, <disp-formula id="FD39"><mml:math id="M80"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:munder></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>s</mml:mi><mml:mo>.</mml:mo><mml:mi>t</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>S</mml:mi><mml:mo>⋅</mml:mo><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>l</mml:mi><mml:mi>b</mml:mi><mml:mo>≤</mml:mo><mml:mi>v</mml:mi><mml:mo>≤</mml:mo><mml:mi>u</mml:mi><mml:mi>b</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mn>0.75</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>z</mml:mi><mml:mo>∗</mml:mo></mml:msup><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mi>u</mml:mi><mml:msub><mml:mi>b</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p id="P84">This LP then obtains the WT optimal flux through the blood demand reaction <inline-formula><mml:math id="M81"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi>W</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>v</mml:mi><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>. The IMD model can be summarised as, <disp-formula id="FD40"><mml:math id="M82"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:munder></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>s</mml:mi><mml:mo>.</mml:mo><mml:mi>t</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>S</mml:mi><mml:mo>⋅</mml:mo><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>l</mml:mi><mml:mi>b</mml:mi><mml:mo>≤</mml:mo><mml:mi>v</mml:mi><mml:mo>≤</mml:mo><mml:mi>u</mml:mi><mml:mi>b</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mn>0</mml:mn><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula> where <inline-formula><mml:math id="M83"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>v</mml:mi><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> is set to the optimal flux value.</p><p id="P85">For the dynamic IMD analysis, this IMD simulation is performed in every FBA step and the solution is used to update the PBPK model iteratively. Therefore, the optimal fluxes <italic>v<sub>WT</sub></italic> and <italic>v<sub>IMD</sub></italic> are added to the venous blood compartment with a correction factor <italic>c</italic> = 0.1, which relaxes the maximisation of the blood demand of a specific compound. Hence, the ODE of the venous blood compartment for the IMD analysis of the WT model can be given as, <disp-formula id="FD41"><label>(37)</label><mml:math id="M84"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>W</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo>⋅</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi>W</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula> and for the IMD model as <disp-formula id="FD42"><label>(38)</label><mml:math id="M85"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="4em"/><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="4em"/><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo>.</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi>I</mml:mi><mml:mi>M</mml:mi><mml:mi>D</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p></sec><sec id="S36"><label>5.6</label><title>Uncertainty Quantification</title><p id="P86">Mathematical models, such as infant-WBMs and PBPK models, attempt to simulate complex biological processes. These models are developed using necessary assumptions about process behaviours, parameters from the literature, and parameter approximations. However, these assumptions and simplifications introduce uncertainties into the models. Uncertainty quantification (UQ) analyses all sources of error and uncertainty in mathematical models. This process assesses the extent to which a model should be trusted rather than determining whether the model is correct or incorrect [<xref ref-type="bibr" rid="R77">77</xref>]. UQ can help assess an uncertain parameter’s impact on a model by studying the relationship between the uncertainty in the output and input of a model [<xref ref-type="bibr" rid="R78">78</xref>].</p><sec id="S37"><label>5.6.1</label><title>Monte-Carlo Simulations</title><p id="P87">To analyse parametric uncertainties in a mathematical model such as the dynamic infant-WBMs, computational methods, such as Monte Carlo simulation, can be applied. This non-intrusive method propagates uncertainties through a mathematical model [<xref ref-type="bibr" rid="R58">58</xref>]. It is based on random sampling. An underlying probability distribution with a probability density function <italic>f</italic> is chosen for this. This distribution could be a continuous uniform distribution in an interval <italic>I</italic> = [<italic>a, b</italic>], <disp-formula id="FD43"><label>(39)</label><mml:math id="M86"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mo>−</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>a</mml:mi><mml:mo>≤</mml:mo><mml:mi>x</mml:mi><mml:mo>≤</mml:mo><mml:mi>b</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>x</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext> </mml:mtext><mml:mi>x</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>b</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p id="P88">Such a uniform distribution can be applied when there is a minimum and maximum value in which the parameter arbitrarily lies. Then, <italic>N</italic> input random variables <inline-formula><mml:math id="M87"><mml:mrow><mml:mi>Z</mml:mi><mml:mo>∈</mml:mo><mml:msup><mml:mi>ℝ</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mrow></mml:math></inline-formula> are generated according to the chosen probability density function <italic>f</italic>. The parameters <italic>Z</italic><sup>(<italic>i</italic>)</sup> with <italic>i</italic> = 1, …, <italic>N</italic> are used as input to the model <italic>m</italic>(<italic>Z</italic><sup>(<italic>i</italic>)</sup>). When evaluating the model output <italic>m</italic>(<italic>Z</italic><sup>(<italic>i</italic>)</sup>), the impact of the variation of the parameter in the interval I on the model output can be assessed. Using these model realisations, the quantity of interest, such as the expected value, can be computed, [<xref ref-type="bibr" rid="R58">58</xref>] <disp-formula id="FD44"><label>(40)</label><mml:math id="M88"><mml:mrow><mml:mi mathvariant="double-struck">E</mml:mi><mml:mo stretchy="false">[</mml:mo><mml:mi>m</mml:mi><mml:mo>(</mml:mo><mml:mi>Z</mml:mi><mml:mo>)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo>≈</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>N</mml:mi></mml:mfrac><mml:mstyle displaystyle="true"><mml:munderover><mml:mi>∑</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mrow><mml:mi>m</mml:mi><mml:mo>(</mml:mo><mml:msup><mml:mi>Z</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mstyle><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p></sec></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental Table 1</label><media xlink:href="EMS201309-supplement-Supplemental_Table_1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplemental Table 2</label><media xlink:href="EMS201309-supplement-Supplemental_Table_2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAcEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplemental Table 3</label><media xlink:href="EMS201309-supplement-Supplemental_Table_3.xls" mimetype="application" mime-subtype="vnd.ms-excel" id="d2aAcEdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Supplemental Table 4</label><media xlink:href="EMS201309-supplement-Supplemental_Table_4.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAcEeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplemental Information</label><media xlink:href="EMS201309-supplement-Supplemental_Information.pdf" mimetype="application" mime-subtype="pdf" id="d2aAcEfB" position="anchor"/></supplementary-material></sec></body><back><ack id="S38"><title>Acknowledgements</title><p>The authors acknowledge the support of the Informatics for Life project funded by the Klaus Tschira Foundation, the financial support by the Dietmar Hopp Foundation, St. Leon Rot, Germany (grant numbers 2311221, 1DH2011117, and 1DH1911376), the financial support by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (#757922 and #101125633), and the Horizon Europe grant Recon4IMD (#101080997). The present work was also supported by the Helmholtz Association under the joint research school HIDSS4Health – Helmholtz Information and Data Science School for Health.</p></ack><fn-group><fn id="FN2" fn-type="con"><p id="P89"><bold>Author contribution</bold>:</p><p id="P90">Conceptualisation E.Z., F.K.M., V.H., I.T.; Methodology E.Z., F.K.M., V.H., I.T.; Software E.Z., F.K.M., I.T.; Data Curation E.Z., F.K.M., I.T.; Writing – Original Draft E.Z., I.T.; Writing – Review &amp; Editing E.Z., F.K.M., U.M., S.K., V.H., I.T.; Supervision U.M., S.K., V.H., I.T.; Funding Acquisition U.M., S.K., V.H., I.T.</p></fn><fn id="FN3" fn-type="conflict"><p id="P91"><bold>Declaration of interest</bold>:</p><p id="P92">The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>[1]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mütze</surname><given-names>U</given-names></name><name><surname>Garbade</surname><given-names>SF</given-names></name><name><surname>Gramer</surname><given-names>G</given-names></name><name><surname>Lindner</surname><given-names>M</given-names></name><name><surname>Freisinger</surname><given-names>Peter</given-names></name><name><surname>Grünert</surname><given-names>Sarah Catharina</given-names></name><name><surname>Hennermann</surname><given-names>Julia</given-names></name><name><surname>Ensenauer</surname><given-names>Regina</given-names></name><name><surname>Thimm</surname><given-names>Eva</given-names></name><name><surname>Zirnbauer</surname><given-names>Judith</given-names></name><name><surname>Leichsenring</surname><given-names>Michael</given-names></name><etal/></person-group><article-title>Long-term Outcomes of Individuals With Metabolic Diseases Identified Through Newborn Screening</article-title><source>Pediatrics</source><year>2020</year><volume>146</volume><issue>5</issue><elocation-id>e20200444</elocation-id><pub-id pub-id-type="pmid">33051224</pub-id></element-citation></ref><ref id="R2"><label>[2]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mütze</surname><given-names>Ulrike</given-names></name><name><surname>Mengler</surname><given-names>Katharina</given-names></name><name><surname>Boy</surname><given-names>Nikolas</given-names></name><name><surname>Gleich</surname><given-names>Florian</given-names></name><name><surname>Opladen</surname><given-names>Thomas</given-names></name><name><surname>Garbade</surname><given-names>Sven F</given-names></name><name><surname>Kölker</surname><given-names>Stefan</given-names></name></person-group><article-title>How longitudinal observational studies can guide screening strategy for rare diseases</article-title><source>Journal of Inherited Metabolic Disease</source><year>2022</year><volume>45</volume><issue>5</issue><fpage>889</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">35488475</pub-id></element-citation></ref><ref id="R3"><label>[3]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mütze</surname><given-names>Ulrike</given-names></name><name><surname>Stengel</surname><given-names>Julia</given-names></name><name><surname>Gleich</surname><given-names>Florian</given-names></name><name><surname>Keler</surname><given-names>Svenja</given-names></name><name><surname>Grunert</surname><given-names>Sarah C</given-names></name><name><surname>Thimm</surname><given-names>Eva</given-names></name><name><surname>Hennermann</surname><given-names>Julia B</given-names></name><name><surname>Freisinger</surname><given-names>Perter</given-names></name><name><surname>Krämer</surname><given-names>Johannes</given-names></name><name><surname>Schnabel-Besson</surname><given-names>Elena</given-names></name><name><surname>Mengler</surname><given-names>Katharina</given-names></name><etal/></person-group><article-title>Md1 : Long-term outcomes of adolescents and young adults identified by metabolic newborn screening</article-title><source>Pediatrics</source><year>2024</year></element-citation></ref><ref id="R4"><label>[4]</label><element-citation publication-type="web"><collab>Gemeinsamer Bundesausschuss</collab><source>Richtlinie des gemeinsamen bundesausschusses über die früherkennung von krankheiten bei kindern</source><date-in-citation>Accessed: 11-07-2022</date-in-citation><comment>https://www.g-ba.de/downloads/62-492-2675/Kinder-RL{\_}2021-09-16{\_}iK-2022-01-01.pdf</comment></element-citation></ref><ref id="R5"><label>[5]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanpher</surname><given-names>Brendan</given-names></name><name><surname>Brunetti-Pierri</surname><given-names>Nicola</given-names></name><name><surname>Lee</surname><given-names>Brendan</given-names></name></person-group><article-title>Inborn errors of metabolism: the flux from mendelian to complex diseases</article-title><source>Nature Reviews Genetics</source><year>2006</year><volume>7</volume><issue>6</issue><fpage>449</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">16708072</pub-id></element-citation></ref><ref id="R6"><label>[6]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>Natalie C</given-names></name><name><surname>Becker</surname><given-names>Scott A</given-names></name><name><surname>Jamshidi</surname><given-names>Neema</given-names></name><name><surname>Thiele</surname><given-names>Ines</given-names></name><name><surname>Mo</surname><given-names>Monica L</given-names></name><name><surname>Vo</surname><given-names>Thuy D</given-names></name><name><surname>Srivas</surname><given-names>Rohith</given-names></name><name><surname>Palsson</surname><given-names>Bernhard O</given-names></name></person-group><article-title>Global reconstruction of the human metabolic network based on genomic and bibliomic data</article-title><source>Proceedings of the National Academy of Sciences</source><year>2007</year><volume>104</volume><issue>6</issue><fpage>1777</fpage><lpage>1782</lpage><pub-id pub-id-type="pmcid">PMC1794290</pub-id><pub-id pub-id-type="pmid">17267599</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0610772104</pub-id></element-citation></ref><ref id="R7"><label>[7]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunk</surname><given-names>E</given-names></name><name><surname>Sahoo</surname><given-names>S</given-names></name><name><surname>Zielinski</surname><given-names>DC</given-names></name><name><surname>Altunkaya</surname><given-names>Ali</given-names></name><name><surname>Dräger</surname><given-names>Andreas</given-names></name><name><surname>Mih</surname><given-names>Nathan</given-names></name><name><surname>Gatto</surname><given-names>Francesco</given-names></name><name><surname>Nilsson</surname><given-names>Avlant</given-names></name><name><surname>Gonzalez</surname><given-names>German Andres Preciat</given-names></name><name><surname>Aurich</surname><given-names>Maike Kathrin</given-names></name><name><surname>Prlić</surname><given-names>Andreas</given-names></name><etal/></person-group><article-title>Recon3D enables a three-dimensional view of gene variation in human metabolism</article-title><source>Nature Biotechnology</source><year>2018</year><volume>36</volume><issue>3</issue><fpage>272</fpage><lpage>281</lpage><pub-id pub-id-type="pmcid">PMC5840010</pub-id><pub-id pub-id-type="pmid">29457794</pub-id><pub-id pub-id-type="doi">10.1038/nbt.4072</pub-id></element-citation></ref><ref id="R8"><label>[8]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swainston</surname><given-names>Neil</given-names></name><name><surname>Smallbone</surname><given-names>Kieran</given-names></name><name><surname>Hefzi</surname><given-names>Hooman</given-names></name><name><surname>Dobson</surname><given-names>Paul</given-names></name><name><surname>Brewer</surname><given-names>Judy</given-names></name><name><surname>Hanscho</surname><given-names>Michael</given-names></name><name><surname>Zielinski</surname><given-names>Daniel</given-names></name><name><surname>Ang</surname><given-names>Kok Siong</given-names></name><name><surname>Gardiner</surname><given-names>Natalie</given-names></name><name><surname>Gutierrez</surname><given-names>Jahir</given-names></name><name><surname>Kyriakopoulos</surname><given-names>Sarantos</given-names></name><etal/></person-group><article-title>Recon 2.2: From reconstruction to model of human metabolism</article-title><source>Metabolomics</source><year>2016</year><month>07</month><volume>12</volume><pub-id pub-id-type="pmcid">PMC4896983</pub-id><pub-id pub-id-type="pmid">27358602</pub-id><pub-id pub-id-type="doi">10.1007/s11306-016-1051-4</pub-id></element-citation></ref><ref id="R9"><label>[9]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiele</surname><given-names>Ines</given-names></name><name><surname>Swainston</surname><given-names>Neil</given-names></name><name><surname>Fleming</surname><given-names>Ronan</given-names></name><name><surname>Hoppe</surname><given-names>Andreas</given-names></name><name><surname>Sahoo</surname><given-names>Swagatika</given-names></name><name><surname>Aurich</surname><given-names>Maike</given-names></name><name><surname>Haraldsdóttir</surname><given-names>Hulda</given-names></name><name><surname>Mo</surname><given-names>Monica</given-names></name><name><surname>Rolfsson</surname><given-names>Ottar</given-names></name><name><surname>Stobbe</surname><given-names>Miranda</given-names></name><name><surname>Thorleifsson</surname><given-names>Stefan</given-names></name><etal/></person-group><article-title>A community-driven global reconstruction of human metabolism</article-title><source>Nature biotechnology</source><year>2013</year><month>03</month><volume>31</volume><fpage>419</fpage><lpage>425</lpage><pub-id pub-id-type="pmcid">PMC3856361</pub-id><pub-id pub-id-type="pmid">23455439</pub-id><pub-id pub-id-type="doi">10.1038/nbt.2488</pub-id></element-citation></ref><ref id="R10"><label>[10]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Hongwu</given-names></name><name><surname>Sorokin</surname><given-names>Anatoly</given-names></name><name><surname>Mazein</surname><given-names>Alexander</given-names></name><name><surname>Selkov</surname><given-names>Alex</given-names></name><name><surname>Selkov</surname><given-names>Evgeni</given-names></name><name><surname>Demin</surname><given-names>Oleg</given-names></name><name><surname>Goryanin</surname><given-names>Igor</given-names></name></person-group><article-title>The edinburgh human metabolic network reconstruction and its functional analysis</article-title><source>Molecular systems biology</source><year>2007</year><volume>3</volume><fpage>135</fpage><pub-id pub-id-type="pmcid">PMC2013923</pub-id><pub-id pub-id-type="pmid">17882155</pub-id><pub-id pub-id-type="doi">10.1038/msb4100177</pub-id></element-citation></ref><ref id="R11"><label>[11]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiele</surname><given-names>Ines</given-names></name><name><surname>Sahoo</surname><given-names>Swagatika</given-names></name><name><surname>Heinken</surname><given-names>Almut</given-names></name><name><surname>Hertel</surname><given-names>Johannes</given-names></name><name><surname>Heirendt</surname><given-names>Laurent</given-names></name><name><surname>Aurich</surname><given-names>Maike K</given-names></name><name><surname>Ronan</surname><given-names>MT</given-names></name></person-group><article-title>Fleming. Personalized whole-body models integrate metabolism, physiology, and the gut microbiome</article-title><source>Mol Syst Biol</source><year>2020</year><volume>16</volume><issue>5</issue><elocation-id>e8982</elocation-id><pub-id pub-id-type="pmcid">PMC7285886</pub-id><pub-id pub-id-type="pmid">32463598</pub-id><pub-id pub-id-type="doi">10.15252/msb.20198982</pub-id></element-citation></ref><ref id="R12"><label>[12]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaunseder</surname><given-names>Elaine</given-names></name><name><surname>Mütze</surname><given-names>Ulrike</given-names></name><name><surname>Okun</surname><given-names>Jürgen G</given-names></name><name><surname>Hoffmann</surname><given-names>Georg F</given-names></name><name><surname>Kölker</surname><given-names>Stefan</given-names></name><name><surname>Heuveline</surname><given-names>Vincent</given-names></name><name><surname>Thiele</surname><given-names>Ines</given-names></name></person-group><article-title>Personalized metabolic whole-body models for newborns and infants predict growth and biomarkers of inherited metabolic diseases</article-title><source>Cell Metabolism</source><year>2024</year><pub-id pub-id-type="pmid">38834070</pub-id></element-citation></ref><ref id="R13"><label>[13]</label><element-citation publication-type="web"><collab>World Health Organization</collab><source>Who child growth standards weight-for-age</source><year>2023</year><date-in-citation>Accessed: 2022-11-23</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/tools/child-growth-standards/standards/weight-for-age">https://www.who.int/tools/child-growth-standards/standards/weight-for-age</ext-link></comment></element-citation></ref><ref id="R14"><label>[14]</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Palsson</surname><given-names>Bernhard O</given-names></name></person-group><chapter-title>Palsson</chapter-title><source>Systems Biology: Constraint-based Reconstruction and Analysis</source><publisher-name>Cambridge University Press</publisher-name><year>2015</year></element-citation></ref><ref id="R15"><label>[15]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BØ</surname><given-names>Palsson</given-names></name><name><surname>Orth</surname><given-names>JD</given-names></name><name><surname>Thiele</surname><given-names>I</given-names></name></person-group><article-title>What is flux balance analysis?</article-title><source>Nat Biotechnol</source><year>2010</year><volume>28</volume><issue>3</issue><fpage>245</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC3108565</pub-id><pub-id pub-id-type="pmid">20212490</pub-id><pub-id pub-id-type="doi">10.1038/nbt.1614</pub-id></element-citation></ref><ref id="R16"><label>[16]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heirendt</surname><given-names>Laurent</given-names></name><name><surname>Arreckx</surname><given-names>Sylvain</given-names></name><name><surname>Pfau</surname><given-names>Thomas</given-names></name><name><surname>Mendoza</surname><given-names>Sebastión N</given-names></name><name><surname>Richelle</surname><given-names>Anne</given-names></name><name><surname>Heinken</surname><given-names>Almut</given-names></name><name><surname>Haraldsdóttir</surname><given-names>Hulda S</given-names></name><name><surname>Wachowiak</surname><given-names>Jacek</given-names></name><name><surname>Keating</surname><given-names>Sarah M</given-names></name><name><surname>Vlasov</surname><given-names>Vanja</given-names></name><etal/></person-group><article-title>Creation and analysis of biochemical constraint-based models using the cobra toolbox v. 3.0</article-title><source>Nature protocols</source><year>2019</year><volume>14</volume><issue>3</issue><fpage>639</fpage><lpage>702</lpage><pub-id pub-id-type="pmcid">PMC6635304</pub-id><pub-id pub-id-type="pmid">30787451</pub-id><pub-id pub-id-type="doi">10.1038/s41596-018-0098-2</pub-id></element-citation></ref><ref id="R17"><label>[17]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bois</surname><given-names>Frédéric Y</given-names></name></person-group><article-title>Physiologically based modelling and prediction of drug interactions</article-title><source>Basic &amp; clinical pharmacology &amp; toxicology</source><year>2010</year><volume>106</volume><issue>3</issue><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">19912164</pub-id></element-citation></ref><ref id="R18"><label>[18]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>Faiz Khan</given-names></name><name><surname>Palukuri</surname><given-names>Meghana Venkata</given-names></name><name><surname>Shivakumar</surname><given-names>Shruti</given-names></name><name><surname>Rengaswamy</surname><given-names>Raghunathan</given-names></name><name><surname>Sahoo</surname><given-names>Swagatika</given-names></name></person-group><article-title>A computational framework for studying gut-brain axis in autism spectrum disorder</article-title><source>Frontiers in Physiology</source><year>2022</year><volume>13</volume><pub-id pub-id-type="pmcid">PMC8940246</pub-id><pub-id pub-id-type="pmid">35330929</pub-id><pub-id pub-id-type="doi">10.3389/fphys.2022.760753</pub-id></element-citation></ref><ref id="R19"><label>[19]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angione</surname><given-names>Claudio</given-names></name></person-group><article-title>Human systems biology and metabolic modelling: A review—from disease metabolism to precision medicine</article-title><source>BioMed Research International</source><year>2019</year><fpage>2019</fpage><pub-id pub-id-type="pmcid">PMC6590590</pub-id><pub-id pub-id-type="pmid">31281846</pub-id><pub-id pub-id-type="doi">10.1155/2019/8304260</pub-id></element-citation></ref><ref id="R20"><label>[20]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordbar</surname><given-names>Aarash</given-names></name><name><surname>Yurkovich</surname><given-names>James T</given-names></name><name><surname>Paglia</surname><given-names>Giuseppe</given-names></name><name><surname>Rolfsson</surname><given-names>Ottar</given-names></name><name><surname>Sigurjónsson</surname><given-names>Ólafur E</given-names></name><name><surname>Palsson</surname><given-names>Bernhard O</given-names></name></person-group><article-title>Elucidating dynamic metabolic physiology through network integration of quantitative time-course metabolomics</article-title><source>Scientific reports</source><year>2017</year><volume>7</volume><issue>1</issue><elocation-id>46249</elocation-id><pub-id pub-id-type="pmcid">PMC5384226</pub-id><pub-id pub-id-type="pmid">28387366</pub-id><pub-id pub-id-type="doi">10.1038/srep46249</pub-id></element-citation></ref><ref id="R21"><label>[21]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannan</surname><given-names>Ahmad A</given-names></name><name><surname>Toya</surname><given-names>Yoshihiro</given-names></name><name><surname>Shimizu</surname><given-names>Kazuyuki</given-names></name><name><surname>McFadden</surname><given-names>Johnjoe</given-names></name><name><surname>Kierzek</surname><given-names>Andrzej M</given-names></name><name><surname>Rocco</surname><given-names>Andrea</given-names></name></person-group><article-title>Integrating kinetic model of e. coli with genome scale metabolic fluxes overcomes its open system problem and reveals bistability in central metabolism</article-title><source>PloS’ one</source><year>2015</year><volume>10</volume><issue>10</issue><elocation-id>e0139507</elocation-id><pub-id pub-id-type="pmcid">PMC4607504</pub-id><pub-id pub-id-type="pmid">26469081</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0139507</pub-id></element-citation></ref><ref id="R22"><label>[22]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zelezniak</surname><given-names>Aleksej</given-names></name><name><surname>Sheridan</surname><given-names>Steven</given-names></name><name><surname>Patil</surname><given-names>Kiran Raosaheb</given-names></name></person-group><article-title>Contribution of network connectivity in determining the relationship between gene expression and metabolite concentration changes</article-title><source>PLoS computational biology</source><year>2014</year><volume>10</volume><issue>4</issue><elocation-id>e1003572</elocation-id><pub-id pub-id-type="pmcid">PMC3998873</pub-id><pub-id pub-id-type="pmid">24762675</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003572</pub-id></element-citation></ref><ref id="R23"><label>[23]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Guebila</surname><given-names>Marouen</given-names></name><name><surname>Thiele</surname><given-names>Ines</given-names></name></person-group><article-title>Dynamic flux balance analysis of whole-body metabolism for type 1 diabetes</article-title><source>Nature Computational Science</source><year>2021</year><volume>1</volume><issue>5</issue><fpage>348</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">38217214</pub-id></element-citation></ref><ref id="R24"><label>[24]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Leo</given-names></name><name><surname>Pei</surname><given-names>William</given-names></name><name><surname>Thiele</surname><given-names>Ines</given-names></name><name><surname>Mahadevan</surname><given-names>Radhakrishnan</given-names></name></person-group><article-title>Integration of a physiologically-based pharmacokinetic model with a whole-body, organ-resolved genome-scale model for characterization of ethanol and acetaldehyde metabolism</article-title><source>PLOS’ Computational Biology</source><year>2021</year><month>08</month><volume>17</volume><elocation-id>e1009110</elocation-id><pub-id pub-id-type="pmcid">PMC8370625</pub-id><pub-id pub-id-type="pmid">34351898</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1009110</pub-id></element-citation></ref><ref id="R25"><label>[25]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frezza</surname><given-names>Christian</given-names></name><name><surname>Zheng</surname><given-names>Liang</given-names></name><name><surname>Folger</surname><given-names>Ori</given-names></name><name><surname>Rajagopalan</surname><given-names>Kartik N</given-names></name><name><surname>MacKenzie</surname><given-names>Elaine D</given-names></name><name><surname>Jerby</surname><given-names>Livnat</given-names></name><name><surname>Micaroni</surname><given-names>Massimo</given-names></name><name><surname>Chaneton</surname><given-names>Barbara</given-names></name><name><surname>Adam</surname><given-names>Julie</given-names></name><name><surname>Hedley</surname><given-names>Ann</given-names></name><etal/></person-group><article-title>Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase</article-title><source>Nature</source><year>2011</year><volume>477</volume><issue>7363</issue><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">21849978</pub-id></element-citation></ref><ref id="R26"><label>[26]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yizhak</surname><given-names>Keren</given-names></name><name><surname>Gaude</surname><given-names>Edoardo</given-names></name><name><surname>Le Dévédec</surname><given-names>Sylvia</given-names></name><name><surname>Waldman</surname><given-names>Yedael Y</given-names></name><name><surname>Stein</surname><given-names>Gideon Y</given-names></name><name><surname>van de Water</surname><given-names>Bob</given-names></name><name><surname>Frezza</surname><given-names>Christian</given-names></name><name><surname>Ruppin</surname><given-names>Eytan</given-names></name></person-group><article-title>Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer</article-title><source>eLife</source><year>2014</year><volume>3</volume><elocation-id>e03641</elocation-id><pub-id pub-id-type="pmcid">PMC4238051</pub-id><pub-id pub-id-type="pmid">25415239</pub-id><pub-id pub-id-type="doi">10.7554/eLife.03641</pub-id></element-citation></ref><ref id="R27"><label>[27]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinken</surname><given-names>Almut</given-names></name><name><surname>Thiele</surname><given-names>Ines</given-names></name></person-group><article-title>Systematic prediction of health-relevant human-microbial cometabolism through a computational framework</article-title><source>Gut Microbes</source><year>2015</year><volume>6</volume><issue>2</issue><fpage>120</fpage><lpage>130</lpage><pub-id pub-id-type="pmcid">PMC4615372</pub-id><pub-id pub-id-type="pmid">25901891</pub-id><pub-id pub-id-type="doi">10.1080/19490976.2015.1023494</pub-id></element-citation></ref><ref id="R28"><label>[28]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shlomi</surname><given-names>Tomer</given-names></name><name><surname>Cabili</surname><given-names>Moran N</given-names></name><name><surname>Ruppin</surname><given-names>Eytan</given-names></name></person-group><article-title>Predicting metabolic biomarkers of human inborn errors of metabolism</article-title><source>Molecular Systems Biology</source><year>2009</year><volume>5</volume><issue>1</issue><fpage>263</fpage><pub-id pub-id-type="pmcid">PMC2683725</pub-id><pub-id pub-id-type="pmid">19401675</pub-id><pub-id pub-id-type="doi">10.1038/msb.2009.22</pub-id></element-citation></ref><ref id="R29"><label>[29]</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Toroghi</surname><given-names>Masood Khaksar</given-names></name><name><surname>Cluett</surname><given-names>William R</given-names></name><name><surname>Mahadevan</surname><given-names>Radhakrishnan</given-names></name></person-group><article-title>A multi-scale model of the whole human body based on dynamic parsimonious flux balance analysis</article-title><source>IFAC-PapersOnLine</source><conf-name>11th IFAC Symposium on Dynamics and Control of Process SystemsIncluding Biosystems DYCOPS-CAB 2016</conf-name><year>2016</year><volume>49</volume><issue>7</issue><fpage>937</fpage><lpage>942</lpage></element-citation></ref><ref id="R30"><label>[30]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>David</given-names></name><name><surname>Sulheim</surname><given-names>Snorre</given-names></name><name><surname>Almaas</surname><given-names>Eivind</given-names></name><name><surname>Segrè</surname><given-names>Daniel</given-names></name></person-group><article-title>Addressing uncertainty in genome-scale metabolic model reconstruction and analysis</article-title><source>Genome Biology</source><year>2021</year><month>02</month><volume>22</volume><pub-id pub-id-type="pmcid">PMC7890832</pub-id><pub-id pub-id-type="pmid">33602294</pub-id><pub-id pub-id-type="doi">10.1186/s13059-021-02289-z</pub-id></element-citation></ref><ref id="R31"><label>[31]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>Brendan</given-names></name><name><surname>Farrah</surname><given-names>Terry</given-names></name><name><surname>Richards</surname><given-names>Matthew</given-names></name><name><surname>Mundy</surname><given-names>Michael</given-names></name><name><surname>Simeonidis</surname><given-names>Vangelis</given-names></name><name><surname>Price</surname><given-names>Nathan</given-names></name></person-group><article-title>Probannoweb and probannopy: probabilistic annotation and gap-filling of metabolic reconstructions</article-title><source>Bioinformatics</source><year>2017</year><month>10</month><pub-id pub-id-type="pmid">29267848</pub-id></element-citation></ref><ref id="R32"><label>[32]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiback</surname><given-names>Sharon J</given-names></name><name><surname>Famili</surname><given-names>Iman</given-names></name><name><surname>Greenberg</surname><given-names>Harvey J</given-names></name><name><surname>Palsson</surname><given-names>Bernhard Ø</given-names></name></person-group><article-title>Monte carlo sampling can be used to determine the size and shape of the steady-state flux space</article-title><source>Journal of Theoretical Biology</source><year>2004</year><volume>228</volume><issue>4</issue><fpage>437</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">15178193</pub-id></element-citation></ref><ref id="R33"><label>[33]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellenberger</surname><given-names>Jan</given-names></name><name><surname>Palsson</surname><given-names>Bernhard Ø</given-names></name></person-group><article-title>Use of randomized sampling for analysis of metabolic networks*</article-title><source>Journal of Biological Chemistry</source><year>2009</year><volume>284</volume><issue>9</issue><fpage>5457</fpage><lpage>5461</lpage><pub-id pub-id-type="pmid">18940807</pub-id></element-citation></ref><ref id="R34"><label>[34]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachance</surname><given-names>Jean-Christophe</given-names></name><name><surname>Lloyd</surname><given-names>Colton</given-names></name><name><surname>Monk</surname><given-names>Jonathan</given-names></name><name><surname>Yang</surname><given-names>Laurence</given-names></name><name><surname>Sastry</surname><given-names>Anand</given-names></name><name><surname>Seif</surname><given-names>Yara</given-names></name><name><surname>Palsson</surname><given-names>Bernhard</given-names></name><name><surname>Rodrigue</surname><given-names>Sébastien</given-names></name><name><surname>Feist</surname><given-names>Adam</given-names></name><name><surname>King</surname><given-names>Zachary</given-names></name><name><surname>Jacques</surname><given-names>Pierre-Étienne</given-names></name></person-group><article-title>Bof-dat: Generating biomass objective functions for genome-scale metabolic models from experimental data</article-title><source>PLOS Computational Biology</source><year>2019</year><month>04</month><volume>15</volume><elocation-id>e1006971</elocation-id><pub-id pub-id-type="pmcid">PMC6497307</pub-id><pub-id pub-id-type="pmid">31009451</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006971</pub-id></element-citation></ref><ref id="R35"><label>[35]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>H</given-names></name><name><surname>Rowland-Yeo</surname><given-names>K</given-names></name></person-group><article-title>Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development</article-title><source>CPT: pharmacometrics &amp; systems pharmacology</source><year>2013</year><volume>2</volume><issue>8</issue><fpage>e63</fpage><pub-id pub-id-type="pmcid">PMC3828005</pub-id><pub-id pub-id-type="pmid">23945604</pub-id><pub-id pub-id-type="doi">10.1038/psp.2013.41</pub-id></element-citation></ref><ref id="R36"><label>[36]</label><element-citation publication-type="web"><source>Density</source><date-in-citation>Accessed: 2023-10-16</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://itis.swiss/virtual-population/tissue-properties/database/density/">https://itis.swiss/virtual-population/tissue-properties/database/density/</ext-link></comment></element-citation></ref><ref id="R37"><label>[37]</label><element-citation publication-type="other"><collab>MedicalNewsToday</collab><source>What is the average length for a baby?</source><date-in-citation>Accessed: 2024-02-06</date-in-citation></element-citation></ref><ref id="R38"><label>[38]</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cramer</surname><given-names>Carl H</given-names></name><name><surname>Brophy</surname><given-names>Patrick D</given-names></name></person-group><chapter-title>Chapter 201 - technical aspects of pediatric continuous renal replacement therapy</chapter-title><person-group person-group-type="editor"><name><surname>Ronco</surname><given-names>Claudio</given-names></name><name><surname>Bellomo</surname><given-names>Rinaldo</given-names></name><name><surname>Kellum</surname><given-names>John A</given-names></name><name><surname>Ricci</surname><given-names>Zaccaria</given-names></name></person-group><source>Critical Care Nephrology (Third Edition)</source><edition>third edition</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier</publisher-name><year>2019</year><fpage>1210</fpage><lpage>1214</lpage><elocation-id>e1</elocation-id></element-citation></ref><ref id="R39"><label>[39]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulin</surname><given-names>Patrick</given-names></name><name><surname>Theil</surname><given-names>Frank-Peter</given-names></name></person-group><article-title>A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery</article-title><source>Journal of Pharmaceutical Sciences</source><year>2000</year><volume>89</volume><issue>1</issue><fpage>16</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10664535</pub-id></element-citation></ref><ref id="R40"><label>[40]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>David S</given-names></name><name><surname>Jewison</surname><given-names>Timothy</given-names></name><name><surname>Guo</surname><given-names>An Chi</given-names></name><name><surname>Wilson</surname><given-names>Michael</given-names></name><name><surname>Knox</surname><given-names>Craig</given-names></name><name><surname>Liu</surname><given-names>Yifeng</given-names></name><name><surname>Djoumbou</surname><given-names>Yannick</given-names></name><name><surname>Mandal</surname><given-names>Rupasri</given-names></name><name><surname>Aziat</surname><given-names>Farid</given-names></name><name><surname>Dong</surname><given-names>Edison</given-names></name><name><surname>Bouatra</surname><given-names>Souhaila</given-names></name><etal/></person-group><article-title>HMDB 3.0—The Human Metabolome Database in 2013</article-title><source>Nucleic Acids Research</source><year>2012</year><month>11</month><volume>41</volume><issue>D1</issue><fpage>D801</fpage><lpage>D807</lpage><pub-id pub-id-type="pmcid">PMC3531200</pub-id><pub-id pub-id-type="pmid">23161693</pub-id><pub-id pub-id-type="doi">10.1093/nar/gks1065</pub-id></element-citation></ref><ref id="R41"><label>[41]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebouche</surname><given-names>Charles J</given-names></name></person-group><article-title>Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism</article-title><source>Annals of the New York Academy of Sciences</source><year>2004</year><volume>1033</volume><issue>1</issue><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">15591001</pub-id></element-citation></ref><ref id="R42"><label>[42]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mütze</surname><given-names>U</given-names></name><name><surname>Henze</surname><given-names>L</given-names></name><name><surname>Gleich</surname><given-names>F</given-names></name><name><surname>Lindner</surname><given-names>Martin</given-names></name><name><surname>Grünert</surname><given-names>Sarah C</given-names></name><name><surname>Spiekerkoetter</surname><given-names>Ute</given-names></name><name><surname>Santer</surname><given-names>René</given-names></name><name><surname>Blessing</surname><given-names>Holger</given-names></name><name><surname>Thimm</surname><given-names>Eva</given-names></name><name><surname>Ensenauer</surname><given-names>Regina</given-names></name><name><surname>Weigel</surname><given-names>Johannes</given-names></name><etal/></person-group><article-title>Newborn screening and disease variants predict neurological outcome in isovaleric aciduria</article-title><source>Journal of Inherited Metabolic Disease</source><year>2021</year><volume>44</volume><issue>4</issue><fpage>857</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">33496032</pub-id></element-citation></ref><ref id="R43"><label>[43]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mütze</surname><given-names>Ulrike</given-names></name><name><surname>Henze</surname><given-names>Lucy</given-names></name><name><surname>Schröter</surname><given-names>Julian</given-names></name><name><surname>Gleich</surname><given-names>Florian</given-names></name><name><surname>Lindner</surname><given-names>Martin</given-names></name><name><surname>Grünert</surname><given-names>Sarah C</given-names></name><name><surname>Spiekerkoetter</surname><given-names>Ute</given-names></name><name><surname>Santer</surname><given-names>René</given-names></name><name><surname>Thimm</surname><given-names>Eva</given-names></name><name><surname>Ensenauer</surname><given-names>Regina</given-names></name><name><surname>Weigel</surname><given-names>Johannes</given-names></name><etal/></person-group><article-title>Isovaleric aciduria identified by newborn screening: Strategies to predict disease severity and stratify treatment</article-title><source>Journal of Inherited Metabolic Disease</source><year>2023</year><volume>46</volume><issue>6</issue><fpage>1063</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">37429829</pub-id></element-citation></ref><ref id="R44"><label>[44]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>Adnan</given-names></name><name><surname>Zahid</surname><given-names>Bakhtyar</given-names></name><name><surname>Khan</surname><given-names>Sarbiland</given-names></name><name><surname>Ahmad</surname><given-names>Samreen</given-names></name></person-group><article-title>Isovaleric acidemia: A rare case of an inborn error of metabolism</article-title><source>Cureus</source><year>2020</year><month>03</month><volume>12</volume><elocation-id>e7150</elocation-id><pub-id pub-id-type="pmcid">PMC7108672</pub-id><pub-id pub-id-type="pmid">32257695</pub-id><pub-id pub-id-type="doi">10.7759/cureus.7150</pub-id></element-citation></ref><ref id="R45"><label>[45]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luis</surname><given-names>Paula</given-names></name><name><surname>Ijlst</surname><given-names>Lodewijk</given-names></name><name><surname>Almeida</surname><given-names>Isabel</given-names></name><name><surname>Duran</surname><given-names>Marinus</given-names></name><name><surname>Mohsen</surname><given-names>Al-Walid</given-names></name><name><surname>Vockley</surname><given-names>Jerry</given-names></name><name><surname>Wanders</surname><given-names>Ronald</given-names></name><name><surname>Silva</surname><given-names>Margarida</given-names></name></person-group><article-title>Role of isovaleryl-coa dehydrogenase and short branched-chain acylcoa dehydrogenase in the metabolism of valproic acid: Implications for the branched-chain amino acid oxidation pathway</article-title><source>Drug metabolism and disposition: the biological fate of chemicals</source><year>2011</year><month>03</month><volume>39</volume><fpage>1155</fpage><lpage>60</lpage><pub-id pub-id-type="pmcid">PMC3127238</pub-id><pub-id pub-id-type="pmid">21430231</pub-id><pub-id pub-id-type="doi">10.1124/dmd.110.037606</pub-id></element-citation></ref><ref id="R46"><label>[46]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björkman</surname><given-names>Sven</given-names></name></person-group><article-title>Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (pbpk) modelling: theophylline and midazolam as model drugs</article-title><source>British Journal of Clinical Pharmacology</source><year>2005</year><volume>59</volume><issue>6</issue><fpage>691</fpage><lpage>704</lpage><pub-id pub-id-type="pmcid">PMC1884855</pub-id><pub-id pub-id-type="pmid">15948934</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2125.2004.02225.x</pub-id></element-citation></ref><ref id="R47"><label>[47]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usher</surname><given-names>Robert</given-names></name><name><surname>Shephard</surname><given-names>Michael</given-names></name><name><surname>Lind</surname><given-names>John</given-names></name></person-group><article-title>The blood volume of the newborn infant and placental transfusion</article-title><source>Acta Paediatrica</source><year>1963</year><volume>52</volume><issue>5</issue><fpage>497</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">14064804</pub-id></element-citation></ref><ref id="R48"><label>[48]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosteller</surname><given-names>RD</given-names></name></person-group><article-title>Simplified calculation of body-surface area</article-title><source>New England Journal of Medicine</source><year>1987</year><volume>317</volume><issue>17</issue><elocation-id>1098</elocation-id><pub-id pub-id-type="pmid">3657876</pub-id></element-citation></ref><ref id="R49"><label>[49]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Minzhi</given-names></name><name><surname>Liu</surname><given-names>Li</given-names></name><name><surname>Jiang</surname><given-names>Minyan</given-names></name><name><surname>Liang</surname><given-names>Cuili</given-names></name><name><surname>Zhao</surname><given-names>Xiaoyuan</given-names></name><name><surname>Cai</surname><given-names>Yanna</given-names></name><name><surname>Sheng</surname><given-names>Huiying</given-names></name><name><surname>Ou</surname><given-names>Zhiying</given-names></name><name><surname>Luo</surname><given-names>Hong</given-names></name></person-group><article-title>Measurement of free carnitine and acylcarnitines in plasma by hilic-esi-ms/ms without derivatization</article-title><source>Journal of Chromatography B</source><year>2013</year><volume>932</volume><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">23816563</pub-id></element-citation></ref><ref id="R50"><label>[50]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toroghi</surname><given-names>Masood Khaksar</given-names></name><name><surname>Cluett</surname><given-names>William R</given-names></name><name><surname>Mahadevan</surname><given-names>Radhakrishnan</given-names></name></person-group><article-title>A personalized multiscale modeling framework for dose selection in precision medicine</article-title><source>Industrial &amp; Engineering Chemistry Research</source><year>2020</year><volume>59</volume><issue>21</issue><fpage>9819</fpage><lpage>9829</lpage></element-citation></ref><ref id="R51"><label>[51]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>SE</given-names></name><name><surname>Evans</surname><given-names>AM</given-names></name></person-group><article-title>Carnitine and acylcarnitines</article-title><source>Clin Pharmacokinet</source><year>2012</year><volume>51</volume><fpage>553</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">22804748</pub-id></element-citation></ref><ref id="R52"><label>[52]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaunseder</surname><given-names>Elaine</given-names></name><name><surname>Mütze</surname><given-names>Ulrike</given-names></name><name><surname>Garbade</surname><given-names>Sven F</given-names></name><name><surname>Haupt</surname><given-names>Saskia</given-names></name><name><surname>Feyh</surname><given-names>Patrik</given-names></name><name><surname>Hoffmann</surname><given-names>Georg F</given-names></name><name><surname>Heuveline</surname><given-names>Vincent</given-names></name><name><surname>Kölker</surname><given-names>Stefan</given-names></name></person-group><article-title>Machine learning methods improve specificity in newborn screening for isovaleric aciduria</article-title><source>Metabolites</source><year>2023</year><volume>13</volume><issue>2</issue><pub-id pub-id-type="pmcid">PMC9962193</pub-id><pub-id pub-id-type="pmid">36837923</pub-id><pub-id pub-id-type="doi">10.3390/metabo13020304</pub-id></element-citation></ref><ref id="R53"><label>[53]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ensenauer</surname><given-names>Regina</given-names></name><name><surname>Fingerhut</surname><given-names>Ralph</given-names></name><name><surname>Maier</surname><given-names>Esther M</given-names></name><name><surname>Polanetz</surname><given-names>Roman</given-names></name><name><surname>Olgemöller</surname><given-names>Bernhard</given-names></name><name><surname>Röschinger</surname><given-names>Wulf</given-names></name><name><surname>Muntau</surname><given-names>Ania C</given-names></name></person-group><article-title>Newborn Screening for Isovaleric Acidemia Using Tandem Mass Spectrometry: Data from 1.6 Million Newborns</article-title><source>Clinical Chemistry</source><year>2011</year><month>04</month><volume>57</volume><issue>4</issue><fpage>623</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">21335445</pub-id></element-citation></ref><ref id="R54"><label>[54]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeber</surname><given-names>JG</given-names></name><name><surname>Platis</surname><given-names>D</given-names></name><name><surname>Zetterström</surname><given-names>RH</given-names></name><name><surname>Almashanu</surname><given-names>Shlomo</given-names></name><name><surname>Boemer</surname><given-names>François</given-names></name><name><surname>Bonham</surname><given-names>James R</given-names></name><name><surname>Borde</surname><given-names>Patricia</given-names></name><name><surname>Brincat</surname><given-names>Ian</given-names></name><name><surname>Cheillan</surname><given-names>David</given-names></name><name><surname>Dekkers</surname><given-names>Eugenie</given-names></name><name><surname>Dimitrov</surname><given-names>Dobry</given-names></name><etal/></person-group><article-title>Neonatal screening in europe revisited: An isns perspective on the current state and developments since 2010</article-title><source>Int J Neonatal Screen</source><year>2021</year><volume>7</volume><issue>1</issue><fpage>15</fpage><pub-id pub-id-type="pmcid">PMC8006225</pub-id><pub-id pub-id-type="pmid">33808002</pub-id><pub-id pub-id-type="doi">10.3390/ijns7010015</pub-id></element-citation></ref><ref id="R55"><label>[55]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLeod</surname><given-names>Erin</given-names></name><name><surname>Ney</surname><given-names>Denise</given-names></name></person-group><article-title>Nutritional management of phenylketonuria</article-title><source>Annales Nestle [English ed.]</source><year>2010</year><month>06</month><volume>68</volume><fpage>58</fpage><lpage>69</lpage><pub-id pub-id-type="pmcid">PMC2901905</pub-id><pub-id pub-id-type="pmid">22475869</pub-id><pub-id pub-id-type="doi">10.1159/000312813</pub-id></element-citation></ref><ref id="R56"><label>[56]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>A</given-names></name><name><surname>van Wegberg</surname><given-names>AMJ</given-names></name><name><surname>Ahring</surname><given-names>K</given-names></name><name><surname>Beblo</surname><given-names>S</given-names></name><name><surname>Bélanger-Quintana</surname><given-names>A</given-names></name><name><surname>Burlina</surname><given-names>A</given-names></name><name><surname>Campistol</surname><given-names>J</given-names></name><name><surname>Coşkun</surname><given-names>T</given-names></name><name><surname>Feillet</surname><given-names>F</given-names></name><name><surname>Giżewska</surname><given-names>M</given-names></name><name><surname>Huijbregts</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Pku dietary handbook to accompany pku guidelines</article-title><source>Orphanet J Rare Dis</source><year>2020</year><month>June</month><volume>15</volume><issue>1</issue><fpage>171</fpage><pub-id pub-id-type="pmcid">PMC7329487</pub-id><pub-id pub-id-type="pmid">32605583</pub-id><pub-id pub-id-type="doi">10.1186/s13023-020-01391-y</pub-id></element-citation></ref><ref id="R57"><label>[57]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>A</given-names></name><name><surname>Daly</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>S</given-names></name><name><surname>Almeida</surname><given-names>MF</given-names></name><name><surname>Assoun</surname><given-names>M</given-names></name><name><surname>Belanger-Quintana</surname><given-names>A</given-names></name><name><surname>Bernabei</surname><given-names>S</given-names></name><name><surname>Boll-halder</surname><given-names>S</given-names></name><name><surname>Cassiman</surname><given-names>D</given-names></name><name><surname>Champion</surname><given-names>H</given-names></name><name><surname>Chan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Dietary practices in isovaleric acidemia: A european survey</article-title><source>Molecular Genetics and Metabolism Reports</source><year>2017</year><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="pmcid">PMC5328917</pub-id><pub-id pub-id-type="pmid">28275552</pub-id><pub-id pub-id-type="doi">10.1016/j.ymgmr.2017.02.001</pub-id></element-citation></ref><ref id="R58"><label>[58]</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>Maqsood Mubarak</given-names></name><name><surname>Kusch</surname><given-names>Jonas</given-names></name></person-group><source>Uncertainty quantification dictionary monte carlo method</source><date-in-citation>Accessed: 29-012024</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://dictionary.helmholtz-uq.de/content/monte_carlo_method.html">https://dictionary.helmholtz-uq.de/content/monte_carlo_method.html</ext-link></comment></element-citation></ref><ref id="R59"><label>[59]</label><element-citation publication-type="other"><collab>The MathWorks Inc</collab><source>Matlab version: 9.9.0.2037887 (r2020b)</source><year>2020</year><comment>update 8</comment></element-citation></ref><ref id="R60"><label>[60]</label><element-citation publication-type="web"><source>Plasma protein binding</source><date-in-citation>Accessed: 2023-11-20</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://revive.gardp.org/resource/plasma-protein-binding/?cf=encyclopaedia">https://revive.gardp.org/resource/plasma-protein-binding/?cf=encyclopaedia</ext-link></comment></element-citation></ref><ref id="R61"><label>[61]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>Tony</given-names></name><name><surname>Dileep</surname><given-names>Uma</given-names></name><name><surname>Vaz</surname><given-names>Mario</given-names></name><name><surname>Fuller</surname><given-names>Malcolm F</given-names></name><name><surname>Kurpad</surname><given-names>Anura V</given-names></name></person-group><article-title>Intestinal microbial contribution to metabolic leucine input in adult men12</article-title><source>The Journal of Nutrition</source><year>2008</year><volume>138</volume><issue>11</issue><fpage>2217</fpage><lpage>2221</lpage><pub-id pub-id-type="pmid">18936222</pub-id></element-citation></ref><ref id="R62"><label>[62]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>Arianna</given-names></name><name><surname>Heinken</surname><given-names>Almut</given-names></name><name><surname>Hertel</surname><given-names>Johannes</given-names></name><name><surname>Smarr</surname><given-names>Larry</given-names></name><name><surname>Li</surname><given-names>Weizhong</given-names></name><name><surname>Treu</surname><given-names>Laura</given-names></name><name><surname>Valle</surname><given-names>Giorgio</given-names></name><name><surname>Campanaro</surname><given-names>Stefano</given-names></name><name><surname>Thiele</surname><given-names>Ines</given-names></name></person-group><article-title>Longitudinal flux balance analyses of a patient with episodic colonic inflammation reveals microbiome metabolic dynamics</article-title><source>Gut microbes</source><year>2023</year><month>01</month><volume>15</volume><elocation-id>2226921</elocation-id><pub-id pub-id-type="pmcid">PMC10339767</pub-id><pub-id pub-id-type="pmid">37438876</pub-id><pub-id pub-id-type="doi">10.1080/19490976.2023.2226921</pub-id></element-citation></ref><ref id="R63"><label>[63]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinelli</surname><given-names>Filippo</given-names></name><name><surname>Heinken</surname><given-names>Almut</given-names></name><name><surname>Henning</surname><given-names>Ann-Kristin</given-names></name><name><surname>Ulmer</surname><given-names>Maria A</given-names></name><name><surname>Hensen</surname><given-names>Tim</given-names></name><name><surname>González</surname><given-names>Antonio</given-names></name><name><surname>Arnold</surname><given-names>Matthias</given-names></name><name><surname>Asthana</surname><given-names>Sanjay</given-names></name><name><surname>Budde</surname><given-names>Kathrin</given-names></name><name><surname>Engelman</surname><given-names>Corinne D</given-names></name><etal/></person-group><article-title>Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in alzheimer’s disease</article-title><source>Scientific Reports</source><year>2024</year><volume>14</volume><issue>1</issue><elocation-id>6095</elocation-id><pub-id pub-id-type="pmcid">PMC10937638</pub-id><pub-id pub-id-type="pmid">38480804</pub-id><pub-id pub-id-type="doi">10.1038/s41598-024-55960-3</pub-id></element-citation></ref><ref id="R64"><label>[64]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearns</surname><given-names>Gregory L</given-names></name><name><surname>Abdel-Rahman</surname><given-names>Susan M</given-names></name><name><surname>Alander</surname><given-names>Sarah W</given-names></name><name><surname>Blowey</surname><given-names>Douglas L</given-names></name><name><surname>Steven Leeder</surname><given-names>J</given-names></name><name><surname>Kauffman</surname><given-names>Ralph E</given-names></name></person-group><article-title>Developmental pharmacology—drug disposition, action, and therapy in infants and children</article-title><source>New England Journal of Medicine</source><year>2003</year><volume>349</volume><issue>12</issue><fpage>1157</fpage><lpage>1167</lpage><pub-id pub-id-type="pmid">13679531</pub-id></element-citation></ref><ref id="R65"><label>[65]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>Iftekhar</given-names></name></person-group><article-title>Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings</article-title><source>Clinical pharmacokinetics</source><year>2014</year><volume>53</volume><fpage>327</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">24515100</pub-id></element-citation></ref><ref id="R66"><label>[66]</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>Aarzoo</given-names></name><name><surname>Parvez</surname><given-names>Md Masud</given-names></name><name><surname>Steven Leeder</surname><given-names>J</given-names></name><name><surname>Prasad</surname><given-names>Bhagwat</given-names></name></person-group><source>Enzyme Kinetics in Drug Metabolism: Fundamentals and Applications</source><publisher-name>Springer US</publisher-name><publisher-loc>New York, NY</publisher-loc><year>2021</year><fpage>551</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">24523105</pub-id></element-citation></ref><ref id="R67"><label>[67]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>Iftekhar</given-names></name></person-group><article-title>A comparison of different methods for the first-in-pediatric dose selection</article-title><source>Journal of Clinical and Translational Research</source><year>2022</year><volume>8</volume><issue>5</issue><fpage>369</fpage><pub-id pub-id-type="pmcid">PMC9741938</pub-id><pub-id pub-id-type="pmid">36518546</pub-id></element-citation></ref><ref id="R68"><label>[68]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Teh-Min</given-names></name></person-group><article-title>A general biphasic bodyweight model for scaling basal metabolic rate, glomerular filtration rate, and drug clearance from birth to adulthood</article-title><source>The AAPS Journal</source><year>2022</year><volume>24</volume><issue>3</issue><fpage>67</fpage><pub-id pub-id-type="pmid">35538161</pub-id></element-citation></ref><ref id="R69"><label>[69]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>Reiko</given-names></name><name><surname>Esaki</surname><given-names>Tsuyoshi</given-names></name><name><surname>Kawashima</surname><given-names>Hitoshi</given-names></name><name><surname>Natsume-Kitatani</surname><given-names>Yayoi</given-names></name><name><surname>Nagao</surname><given-names>Chioko</given-names></name><name><surname>Ohashi</surname><given-names>Rikiya</given-names></name><name><surname>Mizuguchi</surname><given-names>Kenji</given-names></name></person-group><article-title>Predicting fraction unbound in human plasma from chemical structure: Improved accuracy in the low value ranges</article-title><source>Molecular Pharmaceutics</source><year>2018</year><volume>15</volume><issue>11</issue><fpage>5302</fpage><lpage>5311</lpage><pub-id pub-id-type="pmid">30259749</pub-id></element-citation></ref><ref id="R70"><label>[70]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulpuru</surname><given-names>Viswajit</given-names></name><name><surname>Mishra</surname><given-names>Nidhi</given-names></name></person-group><article-title>In silico prediction of fraction unbound in human plasma from chemical fingerprint using automated machine learning</article-title><source>ACS Omega</source><year>2021</year><volume>6</volume><issue>10</issue><fpage>6791</fpage><lpage>6797</lpage><pub-id pub-id-type="pmcid">PMC7970465</pub-id><pub-id pub-id-type="pmid">33748592</pub-id><pub-id pub-id-type="doi">10.1021/acsomega.0c05846</pub-id></element-citation></ref><ref id="R71"><label>[71]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Qassabi</surname><given-names>Jokha</given-names></name><name><surname>Tan</surname><given-names>Shawn</given-names></name><name><surname>Phonboon</surname><given-names>Patcharapan</given-names></name><name><surname>Galetin</surname><given-names>Aleksandra</given-names></name><name><surname>Hodjegan</surname><given-names>Amin Rostami-</given-names></name><name><surname>Scotcher</surname><given-names>Daniel</given-names></name></person-group><article-title>Facing the facts of altered plasma protein binding: Do current models correctly predict changes in fraction unbound in special populations?</article-title><source>Journal of Pharmaceutical Sciences</source><year>2024</year><month>02</month><volume>113</volume><pub-id pub-id-type="pmid">38417790</pub-id></element-citation></ref><ref id="R72"><label>[72]</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gabrielsson</surname><given-names>Johan</given-names></name><name><surname>Weiner</surname><given-names>Daniel</given-names></name></person-group><source>Pharmacokinetic and pharmacodynamic data analysis: concepts and applications</source><publisher-name>CRC press</publisher-name><year>2001</year></element-citation></ref><ref id="R73"><label>[73]</label><element-citation publication-type="web"><source>Introduction to pharmacokinetics part 2</source><date-in-citation>Accessed: 2023-11-20</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="https://d1ssu070pg2v9i.cloudfront.net/pex/wcair/2022/02/11135127/Intro-to-Pharmacokinetics-Pt-2.pdf">https://d1ssu070pg2v9i.cloudfront.net/pex/wcair/2022/02/11135127/Intro-to-Pharmacokinetics-Pt-2.pdf</ext-link></comment></element-citation></ref><ref id="R74"><label>[74]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mc</surname><given-names>Oncley JL</given-names></name><name><surname>Menamy</surname><given-names>RH</given-names></name><name><surname>Lund</surname><given-names>CC</given-names></name></person-group><article-title>Unbound amino acid concentrations in human blood plasmas</article-title><source>J Clin Invest</source><year>1957</year><volume>36</volume><issue>12</issue><pub-id pub-id-type="pmcid">PMC1072779</pub-id><pub-id pub-id-type="pmid">13491698</pub-id><pub-id pub-id-type="doi">10.1172/JCI103568</pub-id></element-citation></ref><ref id="R75"><label>[75]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tada</surname><given-names>Keiya</given-names></name><name><surname>Hirono</surname><given-names>Haruko</given-names></name><name><surname>Arakawa</surname><given-names>Tsuneo</given-names></name></person-group><article-title>Endogenous renal clearance rates of free amino acids in prolinuric and hartnup patients</article-title><source>Tohoku Journal of Experimental Medicine</source><year>1967</year><volume>93</volume><issue>1</issue><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">5586564</pub-id></element-citation></ref><ref id="R76"><label>[76]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shampine</surname><given-names>LF</given-names></name><name><surname>Reichelt</surname><given-names>MW</given-names></name></person-group><article-title>The matlab ode suite</article-title><source>SIAM Journal on Scientific Computing</source><year>1997</year><volume>18</volume><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="R77"><label>[77]</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>TJ</given-names></name></person-group><source>Introduction to uncertainty quantification</source><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><year>2015</year></element-citation></ref><ref id="R78"><label>[78]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saltelli</surname><given-names>Andrea</given-names></name><name><surname>Annoni</surname><given-names>Paola</given-names></name><name><surname>Azzini</surname><given-names>Ivano</given-names></name><name><surname>Campolongo</surname><given-names>Francesca</given-names></name><name><surname>Ratto</surname><given-names>Marco</given-names></name><name><surname>Tarantola</surname><given-names>Stefano</given-names></name></person-group><article-title>Variance based sensitivity analysis of model output design and estimator for the total sensitivity index</article-title><source>Comput Phys Commun</source><year>2010</year><volume>181</volume><fpage>259</fpage><lpage>270</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Schematic overview presenting the coupling of PBPK models [<xref ref-type="bibr" rid="R35">35</xref>] and infant-WBMs [<xref ref-type="bibr" rid="R12">12</xref>] to account for dynamic changes in metabolite concentrations.</p></caption><graphic xlink:href="EMS201309-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Concentration prediction of C5 from the dynamic infant-WBM for the artery and venous blood compartment, as well as the heart, kidney, lung, muscle over different time intervals.</title><p>For (A) a male dynamic infant model and (B) a female dynamic infant model both optimising the growth rate over a two-hour interval. For an IMD analysis comparing (C) a wild type (WT) model and (D) an IVA model. And (E) an IVA model over a 72-hour interval also displaying the time interval, during which newborn screening is usually performed. (F) Predicted changes of C5 in IVA model over a 72-hour interval upon 10% dietary leucine reduction. Note that no further changes have been made to the IVA model. The dashed lines show the 99<sup><italic>th</italic></sup> percentile (0.51 μmol/l) and 99.99<sup><italic>th</italic></sup> percentile (1.37 μmol/l) of blood C5 concentration used as cut-off values for IVA [<xref ref-type="bibr" rid="R53">53</xref>].</p></caption><graphic xlink:href="EMS201309-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Histograms of 100,000 random initialisation of (A) lipophilicity parameter, (B) urinary clearance rate, and (C) fractional unbound plasma evaluated in the venous blood concentration prediction after 2 hours and 100 realisations of two-hour C5 predictions with randomly initialised respective parameter.</p></caption><graphic xlink:href="EMS201309-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Boxplot of C5 prediction of PBPK model after 2 hours based on Monte Carlo Sampling for three uncertain parameters: lipophilicity, renal clearance rate, and unbound plasma rate in (A) the venous blood compartment and (B) the urine.</p></caption><graphic xlink:href="EMS201309-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Concentration prediction of C5 from the dynamic infant-WBM for the artery and venous blood compartment, as well as the heart, kidney, lung, muscle over a five hour interval with the fractional unbound plasma parameter set to <inline-formula><mml:math id="M89"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1.05</mml:mn></mml:mrow></mml:math></inline-formula>. For an IMD analysis comparing (A) a wild type (WT) model and (B) an IVA model over five hours. And (C) an IVA model over a 72-hour interval also displaying the time interval, during which newborn screening is usually performed. The dashed lines show the 99<sup><italic>th</italic></sup> percentile (0.51 μmol/l) and 99.99<sup><italic>th</italic></sup> percentile (1.37 μmol/l) of blood C5 concentration used as cut-off values for IVA [<xref ref-type="bibr" rid="R53">53</xref>].</p></caption><graphic xlink:href="EMS201309-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Overview of general PBPK model. Red arrows describe the blood exchange between artery blood and organs, blue arrows present the blood exchange between venous blood, and organs. The green arrow presents the renal and bile clearance.</p></caption><graphic xlink:href="EMS201309-f006"/></fig></floats-group></article>